[{"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077857"], "brand_name": ["ENOXAPARIN SODIUM"], "generic_name": ["ENOXAPARIN SODIUM"], "manufacturer_name": ["Sandoz Inc"], "product_ndc": ["0781-3238", "0781-3246", "0781-3256", "0781-3262", "0781-3268", "0781-3298", "0781-3299"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["ENOXAPARIN SODIUM"], "rxcui": ["854228", "854235", "854238", "854241", "854245", "854248", "854252"], "spl_id": ["82c50153-58b8-4c35-8fc2-1d9b3d3ac7de"], "spl_set_id": ["38f60bd8-b518-4098-a808-b8f5a3ae6a3a"], "package_ndc": ["0781-3238-01", "0781-3238-63", "0781-3246-02", "0781-3246-64", "0781-3256-03", "0781-3256-66", "0781-3262-04", "0781-3262-68", "0781-3268-05", "0781-3268-69", "0781-3298-04", "0781-3298-68", "0781-3299-05", "0781-3299-69"], "is_original_packager": [true], "unii": ["8NZ41MIK1O"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0179-2024", "product_description": "Enoxaparin Sodium Injection, USP, 150MG/ML Single-Dose Syringes with Automatic Safety Device, For Subcutaneous Injection, Ten 1 mL Syringes per box, Rx Only, Sandoz Inc, Princeton, NJ 08540.  NDC: 0781-3299-69", "product_quantity": "2 units", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch SAH06821A", "more_code_info": ""}, {"status": "Ongoing", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA072695"], "brand_name": ["NORTREL"], "generic_name": ["NORETHINDRONE AND ETHINYL ESTRADIOL"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0555-9008", "0555-9009", "0555-9010"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "rxcui": ["310463", "312033", "748797", "749858", "749869", "749879", "751868", "751870", "751871"], "spl_id": ["191e92be-f23d-40c5-8ad0-3daf5d718604"], "spl_set_id": ["140c50d6-c931-423a-9aa0-526eae7ab93c"], "package_ndc": ["0555-9009-80", "0555-9009-42", "0555-9010-79", "0555-9010-58", "0555-9008-79", "0555-9008-67"], "is_original_packager": [true], "nui": ["N0000175825", "N0000000100", "M0447349", "N0000175602"], "pharm_class_epc": ["Estrogen [EPC]", "Progestin [EPC]"], "pharm_class_moa": ["Estrogen Receptor Agonists [MoA]"], "pharm_class_cs": ["Progesterone Congeners [CS]"], "unii": ["423D2T571U", "T18F433X4S"]}, "product_type": "Drugs", "event_id": "93867", "recalling_firm": "Teva Pharmaceuticals USA, Inc", "address_1": "400 Interpace Pkwy Bldg A", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "nationwide", "recall_number": "D-0321-2024", "product_description": "Nortrel (norethindrone and ethinyl estradiol tablets USP) 0.5/35, packaged in cartons, each carton contains 3 blister cards, each card contains 28 tablets, Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA 19454, NDC 0555-9008-67", "product_quantity": "12,916 cartons", "reason_for_recall": "Discoloration: discolored tablets (shades of blue) mixed in with the white inert remainder tablets.", "recall_initiation_date": "20240125", "center_classification_date": "20240212", "report_date": "20240221", "code_info": "Lot #: 100042978, Exp 7/31/2024"}, {"status": "Terminated", "city": "IRVING", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA216632"], "brand_name": ["CABTREO"], "generic_name": ["CLINDAMYCIN PHOSPHATE/BENZOYL PEROXIDE/ADAPALENE"], "manufacturer_name": ["Bausch Health US LLC"], "product_ndc": ["0187-0006"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["ADAPALENE", "BENZOYL PEROXIDE", "CLINDAMYCIN PHOSPHATE"], "rxcui": ["2668198", "2668204"], "spl_id": ["338bc721-434d-cbc2-e063-6394a90abc47"], "spl_set_id": ["9468da0f-9978-4c58-8135-0274c3415084"], "package_ndc": ["0187-0006-10", "0187-0006-25", "0187-0006-35"], "is_original_packager": [true], "nui": ["N0000175607", "M0018962"], "pharm_class_epc": ["Retinoid [EPC]"], "pharm_class_cs": ["Retinoids [CS]"], "unii": ["1L4806J2QF", "W9WZN9A0GM", "EH6D7113I8"]}, "product_type": "Drugs", "event_id": "94023", "recalling_firm": "MCKESSON CORPORATION", "address_1": "6555 NORTH STATE HIGHWA", "address_2": "N/A", "postal_code": "75039", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0347-2024", "product_description": "CABTREO (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel 1.2%/0.15%/3.1%, Not for Oral, Ophthalmic or Intravaginal Use, Rx Only, Net Wt. 50g, Distributed by Bausch Health US, LLC Bridgewater, NJ 08807 USA, Manufactured by: Bausch Health Companies, Inc. Laval Quebec H7L 448, Canada, NDC 0187-0006-25.", "product_quantity": "42 units", "reason_for_recall": "CGMP Deviations: Product was stored outside labeled storage temperature requirements. Product was exposed to controlled room temperature environment instead of remaining refrigerated.", "recall_initiation_date": "20240212", "center_classification_date": "20240222", "termination_date": "20241001", "report_date": "20240228", "code_info": "Lot: 7001796, Exp 05/31/2025"}, {"status": "Terminated", "city": "Waltham", "state": "MA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020439"], "brand_name": ["BETIMOL"], "generic_name": ["TIMOLOL"], "manufacturer_name": ["Thea Pharma Inc."], "product_ndc": ["82584-001", "82584-002"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["TIMOLOL"], "rxcui": ["208560", "1992305", "2702393", "2702398"], "spl_id": ["3891d7f3-d858-9f71-e063-6394a90af95b"], "spl_set_id": ["3ae775f4-340c-4bf4-aa49-8a31daba0f8b"], "package_ndc": ["82584-001-05", "82584-002-05", "82584-002-15"], "is_original_packager": [true], "upc": ["0382584002053"], "unii": ["817W3C6175"]}, "product_type": "Drugs", "event_id": "94146", "recalling_firm": "Thea Pharma, Inc.", "address_1": "303 Wyman St", "address_2": "N/A", "postal_code": "02451-1208", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide within the United States", "recall_number": "D-0374-2024", "product_description": "Betimol (timolol ophthalmic solution) 0.5%,  15mL bottles, Rx only, Manufactured for: Thea Pharma Inc. Lexington, MA 02420, NDC 82584-002-15", "product_quantity": "5,476 bottles", "reason_for_recall": "Lack of Assurance of Sterility: Out of specification for volume and compromised container closure.", "recall_initiation_date": "20240305", "center_classification_date": "20240311", "termination_date": "20250630", "report_date": "20240320", "code_info": "Lot #: 435019, Exp. Date 11/2024"}, {"status": "Terminated", "city": "Camarillo", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205457"], "brand_name": ["BUDESONIDE"], "generic_name": ["BUDESONIDE"], "manufacturer_name": ["Golden State Medical Supply, Inc."], "product_ndc": ["51407-824"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUDESONIDE"], "rxcui": ["1366550"], "spl_id": ["3c30555b-3552-37a3-e063-6294a90abc68"], "spl_set_id": ["04532cd4-cc79-ef53-e063-6394a90a90ae"], "package_ndc": ["51407-824-30", "5140782430"], "original_packager_product_ndc": ["0591-2510"], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["Q3OKS62Q6X"]}, "product_type": "Drugs", "event_id": "93827", "recalling_firm": "Golden State Medical Supply Inc.", "address_1": "5187 Camino Ruiz", "address_2": "", "postal_code": "93012-8601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Illinois only", "recall_number": "D-0276-2024", "product_description": "Budesonide Extended-Release Tablets, 9 mg, 30-count bottles, Rx only, Marketed by: GSMS, Incorporated, Camarillo, CA, UPC 5140782430, NDC 51407-824-30", "product_quantity": "108 bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20240112", "center_classification_date": "20240129", "termination_date": "20250320", "report_date": "20240207", "code_info": "Lot #: GS054862, Exp. Date 07/31/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0196-2024", "product_description": "RIVASTIGMINE TRANSDERMAL SYSTEM, Delivers 4.6 mg/24 hours, 30 systems per box, Rx Only, Distributed by: Alvogen, Inc., Morristown, NJ 07960.  NDC 47781-304-03", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch P0248AL0AT", "more_code_info": ""}, {"status": "Ongoing", "city": "Boca Raton", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94015", "recalling_firm": "Global Corporation", "address_1": "621 Nw 53rd St Ste 240", "address_2": "N/A", "postal_code": "33487-8291", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0386-2024", "product_description": "Broncochem Cold & Flu Syrup Kids (acetaminophen, guaifenesin, phenylephrine HCl), packaged in 120 mL bottles, Made in Dominican Republic Exclusively for Global Corporation Inc, Boca Raton, FL 33187 USA, NDC 65131-098-44", "product_quantity": "9831 bottles", "reason_for_recall": "Stability testing failures for one or two of the four active pharmaceutical ingredients among the finished drug products, i.e., Phenylephrine HCL, and/or Chlorpheniramine Maleate.", "recall_initiation_date": "20240216", "center_classification_date": "20240314", "report_date": "20240320", "code_info": "Lot #: 223002, Exp. Date 10/2025; 223063, Exp. Date 02/2026"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"brand_name": ["ARMOUR THYROID"], "generic_name": ["THYROID, PORCINE"], "manufacturer_name": ["Allergan, Inc."], "product_ndc": ["0456-0457", "0456-1045", "0456-0458", "0456-0459", "0456-0460", "0456-0461", "0456-0462", "0456-0463", "0456-0464"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SUS SCROFA THYROID"], "rxcui": ["198278", "208534", "208535", "208540", "208543", "208544", "208545", "208547", "208549", "208551", "313385", "313387", "313391", "313393", "314267", "315235"], "spl_id": ["a8878da0-2056-4eee-925e-3d96c6dbc334"], "spl_set_id": ["56b41079-60db-4256-9695-202b3a65d13d"], "package_ndc": ["0456-0457-01", "0456-1045-01", "0456-0458-01", "0456-0458-11", "0456-0458-63", "0456-0459-01", "0456-0459-11", "0456-0459-63", "0456-0460-01", "0456-0461-01", "0456-0461-11", "0456-0461-63", "0456-0462-01", "0456-0463-01", "0456-0464-01"], "is_original_packager": [true], "unii": ["6RV024OAUQ"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0168-2024", "product_description": "ARMOUR THYROID (thyroid tablets, USP), 2 GRAIN (120 mg), 100 Tablets, Rx Only, Distributed by: Allergan US, INc., Madison, NJ 07940.  NDC: 0456-0461-01", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch W05543", "more_code_info": ""}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0311-2024", "product_description": "Up&Up brand dry eye relief (Carboxymethylcellulose 0.5%) packaged in 0.5 FL OZ (15 mL) each bottles (Twin Pack), Distributed by: Target Corporation Minneapolis, MN 55403, NDC 76168-800-30", "product_quantity": "137,544 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93935", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to three direct accounts in NM, AZ and UT.", "recall_number": "D-0373-2024", "product_description": "Bicillin L-A (Penicillin G Benzathine) 1.2, MMU / 2 mL Injection Prefilled Syringe 2 mL, Rx only, Mfg: Pfizer Pharmaceuticals, NDC 60793-0701-10", "product_quantity": "70 vials", "reason_for_recall": "cGMP Deviations: Products were stored outside the drug label specifications.", "recall_initiation_date": "20240207", "center_classification_date": "20240308", "termination_date": "20240814", "report_date": "20240320", "code_info": "567951"}, {"status": "Ongoing", "city": "Texarkana", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M007"], "brand_name": ["MAGNESIUM CITRATE"], "generic_name": ["FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE"], "manufacturer_name": ["Pharma Nobis, LLC"], "product_ndc": ["82645-311"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["MAGNESIUM CITRATE"], "rxcui": ["1052760"], "spl_id": ["0d1c5d55-b64c-8097-e063-6394a90a25ca"], "spl_set_id": ["f0488c86-6c74-3987-e053-2a95a90a31b4"], "package_ndc": ["82645-311-10"], "is_original_packager": [true], "upc": ["0382645311100"], "unii": ["RHO26O1T9V"]}, "product_type": "Drugs", "event_id": "93682", "recalling_firm": "Pharma Nobis LLC", "address_1": "7400 Alumax Rd", "address_2": "N/A", "postal_code": "75501-0282", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide.", "recall_number": "D-0230-2024", "product_description": "Freskaro refresh & revitalize Magnesium Citrate Saline Laxative Oral Solution Grape Flavor 10 fl. oz, Manufactured by: Pharma Lobis, 7400 Alumax Dr., Texarkana, TX 75501, NDC 82645-311-10.", "product_quantity": "53,268 Bottles", "reason_for_recall": "MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.", "recall_initiation_date": "20231221", "center_classification_date": "20240112", "report_date": "20240124", "code_info": "Lot A80553; Exp. 11/2025"}, {"status": "Ongoing", "city": "Texarkana", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M007"], "brand_name": ["MAGNESIUM CITRATE"], "generic_name": ["MAGNESIUM CITRATE"], "manufacturer_name": ["AMERISOURCE BERGEN"], "product_ndc": ["46122-741"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["MAGNESIUM CITRATE"], "rxcui": ["1052760"], "spl_id": ["29f9080b-baf4-6e18-e063-6294a90a46a2"], "spl_set_id": ["f3847b0f-802d-73d7-e053-2a95a90a5bbe"], "package_ndc": ["46122-741-38"], "is_original_packager": [true], "unii": ["RHO26O1T9V"]}, "product_type": "Drugs", "event_id": "93682", "recalling_firm": "Pharma Nobis LLC", "address_1": "7400 Alumax Rd", "address_2": "N/A", "postal_code": "75501-0282", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide.", "recall_number": "D-0227-2024", "product_description": "Good Neighbor Pharmacy, DYE FREE, SUGAR FREE Magnesium Citrate Saline Laxative, Oral Solution, Cherry Flavor 10 fl. oz, Distributed by AmerisourceBergen, 1 West First Ave, Conshochoken, PA 19428, NDC 46122-741-38", "product_quantity": "24,684 Bottles", "reason_for_recall": "MICROBIAL CONTAMINATION OF NON-STERILE PRODUCTS - Presence of Acetobacter nitrogenifigens bacteria.", "recall_initiation_date": "20231221", "center_classification_date": "20240112", "report_date": "20240124", "code_info": "Lots A80673, A80742; Exp 10/31/2025"}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0248-2024", "product_description": "Secret OUTLAST Dry Spray, (Aluminum chlorohydrate 23.5%), Antiperspirant, Protecting Powder, Topical spray can 3.8 oz (107 g), Dist. by: Procter & Gamble, Cincinnati, OH 45202. NDC: 69423-478-10, UPC 0 37000 74772 7", "product_quantity": "unknown", "reason_for_recall": "CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "All lots with expiry through September, 2023"}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0302-2024", "product_description": "Velocity Pharma brand Lubricating Eye Drop (Propylene glycol Eye Drops 0.6%), packaged in 3 bottles of 0.33 FL OZ (10 mL) each, Velocity Pharma, NDC 76168-502-30", "product_quantity": "2,820 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Ongoing", "city": "Minneapolis", "state": "MN", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93940", "recalling_firm": "IntegraDose Compounding Services LLC", "address_1": "719 Kasota Ave Se", "address_2": "N/A", "postal_code": "55414-2842", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MN", "recall_number": "D-0325-2024", "product_description": "Vasopressin 2 Units/2 mL in 0.9% Sodium Chloride Sterile Syringe for Injection, Concentration: 1 Unit/mL, 2 mL Syringe, Rx Only, 719 Kasota Ave SE, Minneapolis, MN, Compounded Drug Not for Resale. Office Use Only, NDC 71139-0190-1.", "product_quantity": "1,299 syringes", "reason_for_recall": "Sub-potent drug: failure to maintain potency through the duration of the labeled expiration/beyond-use date.", "recall_initiation_date": "20240122", "center_classification_date": "20240215", "report_date": "20240221", "code_info": "Lot #s:  20230929VAS-2, Exp. 02/29/2024; 20231004VAS-2, Exp. 04/01/2024; Lot 20231010VAS-2,Exp. 04/07/2024; Lot 20231013VAS-2, Exp. 04/10/2024"}, {"status": "Ongoing", "city": "New York", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93681", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "N/A", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico.", "recall_number": "D-0233-2024", "product_description": "4.2% Sodium Bicarbonate Injection, USP 5 mEq/10 mL (0.5 mEq/mL), Glass ABBOJECT Unit of Use Syringe, For Intravenous Use, Rx Only, 10 mL Syringe per Carton, Hospira, Inc., Lake Forst, IL 60045, NDC 0409-5534-24 (carton), 0409-5534-14 (case).", "product_quantity": "34000 Cartons", "reason_for_recall": "Presence of Particulate Matter; identified as glass", "recall_initiation_date": "20231221", "center_classification_date": "20240117", "report_date": "20240124", "code_info": "Lot GX1542, Exp. 01/01/2025"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA200292"], "brand_name": ["DONEPEZIL HYDROCHLORIDE"], "generic_name": ["DONEPEZIL HYDROCHLORIDE"], "manufacturer_name": ["Solco Healthcare US, LLC"], "product_ndc": ["43547-275", "43547-276"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DONEPEZIL HYDROCHLORIDE"], "rxcui": ["997223", "997229"], "spl_id": ["dcfd9a94-e1bc-4b53-ae6f-0200ee714917"], "spl_set_id": ["042a59ea-131a-4806-b0f4-2f791d4414e2"], "package_ndc": ["43547-275-03", "43547-275-09", "43547-275-11", "43547-276-03", "43547-276-09", "43547-276-11"], "is_original_packager": [true], "upc": ["0343547276034", "0343547275037"], "unii": ["3O2T2PJ89D"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0177-2024", "product_description": "Donepezil HCl Tablets, 5 mg, 90 Tablets, Rx only, Distributed by: Solco Healthcare U.S. LLC, Hurracao, Puerto Rico 00791.  NDC: 43547-275-09", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 17605", "more_code_info": ""}, {"status": "Ongoing", "city": "Westport", "state": "CT", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "89601", "recalling_firm": "TCP HRB ACQUISITON LLC", "address_1": "270 Saugatuck Ave", "address_2": "", "postal_code": "06880-6431", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the US and Canada", "recall_number": "D-0208-2024", "product_description": "Sure Unscented Anti-perspirant Deodorant Aerosol (Aluminum Chlorohydrate 10%), packaged in 6 oz (170 g) aerosol cans, Distributed by Idelle Labs, Ltd., El Paso, TX 79912, NDC 41595-5517-06", "product_quantity": "0.5 million", "reason_for_recall": "Chemical contamination: Presence of benzene", "recall_initiation_date": "20220216", "center_classification_date": "20231228", "report_date": "20240103", "code_info": "All lots, expiry on or before August 2023", "more_code_info": ""}, {"status": "Ongoing", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205457"], "brand_name": ["BUDESONIDE"], "generic_name": ["BUDESONIDE"], "manufacturer_name": ["Actavis Pharma, Inc."], "product_ndc": ["0591-2510"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUDESONIDE"], "rxcui": ["1366550"], "spl_id": ["5ca0f26d-d156-4a05-9a6a-22465f3f9813"], "spl_set_id": ["41d4fd39-81ee-41be-b34d-efb12b3a359d"], "package_ndc": ["0591-2510-30"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["Q3OKS62Q6X"]}, "product_type": "Drugs", "event_id": "93740", "recalling_firm": "Teva Pharmaceuticals USA, Inc", "address_1": "400 Interpace Pkwy Bldg A", "address_2": "", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0275-2024", "product_description": "Budesonide Extended-Release Tablets 9mg, 30-count bottle, Rx Only,  Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314 USA, Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054 USA, NDC 0591-2510-30", "product_quantity": "10,672 30-count bottles", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20240108", "center_classification_date": "20240126", "report_date": "20240207", "code_info": "Lot # 100047273; Exp. 07/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93710", "recalling_firm": "Denver Solutions, LLC DBA Leiters Health", "address_1": "13796 Compark Blvd", "address_2": "", "postal_code": "80112-7145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0281-2024", "product_description": "VANCOmycin HCl PF 1.25g added to 0.9% Sodium Chloride 250 mL IV bag, Item F3206, for IV use only; Leiters 13796 Compark Blvd Englewood, CO 80112; NDC 71449-028-68.", "product_quantity": "10,152 IV bags", "reason_for_recall": "Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.", "recall_initiation_date": "20231228", "center_classification_date": "20240129", "report_date": "20240207", "code_info": "Lot #: 2331184, Exp. Date  02/13/2024; 2331185, Exp. Date  02/10/2024; 2331189, Exp. Date 02/20/2024; 2331191, Exp. Date 02/24/2024; 2331258,Exp. Date 03/03/2024; 2331317, Exp. Date 03/15/2024.", "more_code_info": ""}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93710", "recalling_firm": "Denver Solutions, LLC DBA Leiters Health", "address_1": "13796 Compark Blvd", "address_2": "", "postal_code": "80112-7145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0277-2024", "product_description": "FentaNYL citrate PF, 1000 mcg per 100 mL 0.9% Sodium Chloride (10 mcg per mL), Item F3355, for IV use only; Leiters 13796 Compark Blvd Englewood, CO 80112; NDC 71449-072-41.", "product_quantity": "8,976 IV bags", "reason_for_recall": "Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.", "recall_initiation_date": "20231228", "center_classification_date": "20240129", "report_date": "20240207", "code_info": "Lot #: 2331062, Exp. Date: 02/08/2024; 2331224, Exp. Date 03/18/2024; 2331270, Exp. Date 03/28/2024.", "more_code_info": ""}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0290-2024", "product_description": "CVS Health brand Lubricant Eye Drops (Carboxymethylcellulose Sodium 0.5%), packaged in a) 0.5 FL OZ (15mL) bottles (Single Pack)  (NDC 76168-702-15) and b) 0.5 FL OZ (15 mL) bottles (Twin pack) (NDC 76168-702-30), Distributed by: CVS Pharmacy Inc. One CVS Drive Woonsocket, RI 02895.", "product_quantity": "386,256 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA214585"], "brand_name": ["MESALAMINE"], "generic_name": ["MESALAMINE"], "manufacturer_name": ["Sun Pharmaceutical Industries Inc."], "product_ndc": ["63304-089"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MESALAMINE"], "rxcui": ["476362"], "spl_id": ["d41a599a-71be-4294-9b53-d1cbefe905d5"], "spl_set_id": ["c2f84490-70b8-4998-907d-a77e9f791de1"], "package_ndc": ["63304-089-13"], "is_original_packager": [true], "upc": ["0363304089134"], "nui": ["N0000175781", "M0000971"], "pharm_class_epc": ["Aminosalicylate [EPC]"], "pharm_class_cs": ["Aminosalicylic Acids [CS]"], "unii": ["4Q81I59GXC"]}, "product_type": "Drugs", "event_id": "93909", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0350-2024", "product_description": "Mesalamine Extended-Release Capsules, USP 500mg, Rx Only, 120 Capsules per bottle, Manufactured by: Sun Pharmaceutical Industries Limited, Mohali, INDIA, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, NDC 63304-089-13.", "product_quantity": "54,960 bottles", "reason_for_recall": "Failed Dissolution Specifications: Out of specification for dissolution.", "recall_initiation_date": "20240205", "center_classification_date": "20240223", "report_date": "20240306", "code_info": "Lot #s: MHD0606A, MHD0612A, Exp. 04/30/2024; MHD0613A, MHD0652A, MHD0657A, MHD0672A, MHD0673A, Exp. 05/31/2024; MHD0767A, MHD0768A, MHD0769A, MHD0785A, MHD0799A, MHD0800A, MHD0801A, Exp. 06/30/2024; MHD0827A, MHD0828A, MHD0875A, MHD0876A, MHD0898A, MHD0901A, Exp. 07/31/2024; MHD1081A, MHD1082A, MHD1087A Exp. 09/30/2024.", "more_code_info": ""}, {"status": "Completed", "city": "Mooresville", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93869", "recalling_firm": "Bestco LLC", "address_1": "288 Mazeppa Rd", "address_2": "N/A", "postal_code": "28115-7928", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0328-2024", "product_description": "CVS Health Cherry Cough Drops, Menthol cough suppressant/Oral Anesthetic, 160 drops per bag, item number 20001089, Bestco, 288 Mazeppa Road, Mooresville, NC 28115", "product_quantity": "78 cases/18 packs each", "reason_for_recall": "CGMP Deviations: Potential Glass and Silicone particulates in product", "recall_initiation_date": "20240119", "center_classification_date": "20240216", "report_date": "20240228", "code_info": "100042059, Exp 12/31/2026"}, {"status": "Ongoing", "city": "Mississauga", "state": "", "country": "Canada", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "94066", "recalling_firm": "Contract Pharmaceuticals Limited Canada", "address_1": "7600 East Danbro Cres", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S. and Puerto Rico", "recall_number": "D-0364-2024", "product_description": "Clindamycin Phosphate, Topical Solution USP, 1%, 60 mL, Rx Only, Manufactured for and Distributed by: Marlex Pharmaceuticals, Inc., New Castle, DE 19720, NDC 10135-0691-61", "product_quantity": "45,875 bottles", "reason_for_recall": "Defective Container: Out of specification for weight due to a slow leakage at the 12-month stability timepoint.", "recall_initiation_date": "20240220", "center_classification_date": "20240301", "report_date": "20240313", "code_info": "Lot #: 119466, 119467 Exp 04/2025; 120351 Exp 08/2025; 121712 Exp 11/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0249-2024", "product_description": "Old Spice Pure Sport 2021 Gift Set, Contains: Old Spice Pure Sport Body Wash 18 Fl Oz (532 mL), 2-in-1 Shampoo & Conditioner 13.5 Fl Oz (400 mL),  and Old Spice, SWEAT DEFENSE PURE SPORT PLUS, Dry Spray,  (Aluminum Chlorohydrate 23.5%), Anti-Perspirant, Topical spray can, Net WT 3.8 oz (107 g). Dist. by: Procter & Gamble, Cincinnati, OH 45202. Gift Set NDC 69423-590-01, UPC 12044 04853 5", "product_quantity": "unknown", "reason_for_recall": "CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "All lots with expiry through September 2023"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021395"], "brand_name": ["SPIRIVA"], "generic_name": ["TIOTROPIUM BROMIDE"], "manufacturer_name": ["Boehringer Ingelheim Pharmaceuticals, Inc."], "product_ndc": ["0597-0075"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL", "RESPIRATORY (INHALATION)"], "substance_name": ["TIOTROPIUM BROMIDE MONOHYDRATE"], "rxcui": ["485032", "580261"], "spl_id": ["902426f3-c843-416d-a1e3-b64eafc1f32d"], "spl_set_id": ["820839ef-e53d-47e8-a3b9-d911ff92e6a9"], "package_ndc": ["0597-0075-41", "0597-0075-75", "0597-0075-47"], "is_original_packager": [true], "unii": ["L64SXO195N"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0197-2024", "product_description": "SPIRIVA HANDIHALER (tiotropium bromide inhalation powder) 18 mcg/Capsule, 30 capsules, 3 blister cards, each card contains 10 capsules, Rx only, For oral inhalation only, Distributed by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA.  NDC: 0597-0075-41", "product_quantity": "5 units", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 104440", "more_code_info": ""}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["M019"], "brand_name": ["SECRET ANTIPERSPIRANT"], "generic_name": ["ALUMINUM CHLOROHYDRATE"], "manufacturer_name": ["The Procter & Gamble Manufacturing Company"], "product_ndc": ["37000-134"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ALUMINUM CHLOROHYDRATE"], "spl_id": ["28f210ab-96a1-6ed4-e063-6294a90ada78"], "spl_set_id": ["9f9720c0-a2d7-449c-b97c-19b980322b05"], "package_ndc": ["37000-134-11", "37000-134-17", "37000-134-01"], "is_original_packager": [true], "unii": ["HPN8MZW13M"], "upc": ["037000711094", "037000711087", "037000586906"]}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0242-2024", "product_description": "Secret, powder fresh, Aluminum chlorohydrate 24%, Anti-Perspirant/Deodorant, Topical spray can Net Wt., (a) 4OZ (113g), NDC 37000-134-11, UPC 0 37000 71109 4, (b) 6OZ (170g),  NDC 37000-134-17, UPC 0 37000 71108 7; (c) twin pack-2 each can Net Wt. 6OZ (170g),  NDC: 37000-134-01, UPC 0 37000 58690 6; Distr. by: Procter & Gamble, Cincinnati, OH 45202", "product_quantity": "unknown", "reason_for_recall": "Chemical contamination: presence of benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "Lot #: (a &b) 00701458SJ, 00861458SA, 00871458SA, Exp 1/28/2022; 00921458SK, Exp 3/31/2022; 01701458SJ, 01711458SE, Exp 5/31/2022; 03431458SA, 03441458SA, 03531458SM, Exp 11/30/2022; 10681458SJ, 10691458SA, 10701458SA, 10781458SE, 10811458SJ, Exp 2/28/2023; 11701458SH, 11711458SH, 11721458SG, Exp 5/31/2023; 12181458SD, Exp 7/31/23; 12631458SH,12641458SB, 12651458SE, Exp 8/31/23; 10301458SA,Exp 12/31/22; 10921458SJ, 10931458SA, 11191458SJ, Exp 3/31/23; 11251458SB, 11421458SM, 11431458SB, Exp 4/30/2023; 11701458SH, 11711458SB, Exp 5/31/2023; 12101458SJ, 12121458SJ, Exp 6/30/2023  (c) 11711458SB, Exp 5/31/2023"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040616"], "brand_name": ["WARFARIN SODIUM"], "generic_name": ["WARFARIN SODIUM"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-1712", "0093-1713", "0093-1714", "0093-1715", "0093-1716", "0093-1721", "0093-1718", "0093-1723", "0093-1720"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["WARFARIN SODIUM"], "rxcui": ["855288", "855296", "855302", "855312", "855318", "855324", "855332", "855338", "855344"], "spl_id": ["b8c33971-54b3-4971-bf7f-1bec66999a29"], "spl_set_id": ["0cbce382-9c88-4f58-ae0f-532a841e8f95"], "package_ndc": ["0093-1712-01", "0093-1712-10", "0093-1713-01", "0093-1713-10", "0093-1714-01", "0093-1714-10", "0093-1715-01", "0093-1716-01", "0093-1716-10", "0093-1721-01", "0093-1721-10", "0093-1718-01", "0093-1723-01", "0093-1720-01"], "is_original_packager": [true], "upc": ["0300931721013", "0300931713018", "0300931714015", "0300931723017", "0300931716019", "0300931715012"], "unii": ["6153CWM0CL"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0201-2024", "product_description": "Warfarin Sodium Tablets, USP, 5 mg, 100 Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054.  NDC:  0093-1721-01", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 2323041", "more_code_info": ""}, {"status": "Completed", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA208066"], "brand_name": ["LURASIDONE HYDROCHLORIDE"], "generic_name": ["LURASIDONE HYDROCHLORIDE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["47335-578", "47335-684", "47335-639", "47335-685", "47335-579"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LURASIDONE HYDROCHLORIDE"], "rxcui": ["1040031", "1040041", "1235247", "1297278", "1431235"], "spl_id": ["2ebf334e-6f66-4ef7-b0ca-9d21ccb3165e"], "spl_set_id": ["6d97d871-66d3-4ed8-bbc5-0620e9f69ae5"], "package_ndc": ["47335-578-83", "47335-578-81", "47335-578-13", "47335-684-83", "47335-684-81", "47335-684-13", "47335-639-83", "47335-639-81", "47335-639-13", "47335-685-83", "47335-685-81", "47335-685-13", "47335-579-83", "47335-579-81", "47335-579-13"], "is_original_packager": [true], "unii": ["O0P4I5851I"]}, "product_type": "Drugs", "event_id": "93820", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0266-2024", "product_description": "Lurasidone Hydrochloride Tablets 60mg, Rx Only, 30 Tablets per bottle, Distributed by:  Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Survey No. 259/15, Dadra-396 191(U.T. of D & NH), INDIA, NDC 47335-639-83.", "product_quantity": "11,400 bottles", "reason_for_recall": "CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.", "recall_initiation_date": "20240118", "center_classification_date": "20240125", "report_date": "20240131", "code_info": "Lot #: DNE0620A  Exp. 05/31/2025"}, {"status": "Ongoing", "city": "Westport", "state": "CT", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "89601", "recalling_firm": "TCP HRB ACQUISITON LLC", "address_1": "270 Saugatuck Ave", "address_2": "", "postal_code": "06880-6431", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the US and Canada", "recall_number": "D-0207-2024", "product_description": "Brut Classic Antiperspirant & Deodorant (aluminum chlorohydrate 20.9%) packaged in a) 4 oz. (113g) aerosol cans (UPC 00827755070085, NDC 41595-7103-1) and b) 6 oz. (170g) aerosol cans (UPC 00827755070108, NDC 41595-7103-2), Distributed by Idelle Labs, Ltd. El Paso, TX 79912 USA", "product_quantity": "a) 0.4 million cans, b) 3.4 million cans", "reason_for_recall": "Chemical contamination: Presence of benzene", "recall_initiation_date": "20220216", "center_classification_date": "20231228", "report_date": "20240103", "code_info": "All lots, expiry on or before August 2023", "more_code_info": ""}, {"status": "Completed", "city": "Central Islip", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA211592"], "brand_name": ["VIGABATRIN"], "generic_name": ["VIGABATRIN"], "manufacturer_name": ["Cipla USA, Inc."], "product_ndc": ["69097-964"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["VIGABATRIN"], "rxcui": ["250820"], "spl_id": ["4cdad60f-7614-47cb-8594-3c0257e55c28"], "spl_set_id": ["823cc915-0350-4780-85ed-cd1c338e429d"], "package_ndc": ["69097-964-53"], "is_original_packager": [true], "nui": ["N0000175753"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "unii": ["GR120KRT6K"]}, "product_type": "Drugs", "event_id": "93422", "recalling_firm": "InvaGen Pharmaceuticals, Inc.", "address_1": "550 S Research Pl", "address_2": "", "postal_code": "11722-4415", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0220-2024", "product_description": "Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by: InvaGen Pharmaceuticals, Inc., (a subsidiary of Cipla Ltd.), Hauppauge, NY, 11788, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, NDC 69097-964-53", "product_quantity": "1240 boxes", "reason_for_recall": "Defective Container: powder may leak out of the pouch", "recall_initiation_date": "20231117", "center_classification_date": "20240108", "report_date": "20240117", "code_info": "Lot #: NB301030, Exp. Date 03/31/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0199-2024", "product_description": "Triamterene and Hydrochlorothiazide Capsules, USP,  37.5 mg/25 mg, 100 capsules per bottle, Rx Only, Distributed by: Lannett Company, Inc, Philadelphia, PA 19136.  NDC 0527-1632-01", "product_quantity": "2 units", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 21000279A, 21000280A", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["NASAL DECONGESTANT PE"], "generic_name": ["PHENYLEPHRINE HCL"], "manufacturer_name": ["Cardinal Health 110, LLC. DBA Leader"], "product_ndc": ["70000-0126"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["PHENYLEPHRINE HYDROCHLORIDE"], "rxcui": ["1049182"], "spl_id": ["5217c596-a8d8-4474-bd8a-befc867afd43"], "spl_set_id": ["0e804d71-1a61-4131-9b00-fde3ada7c7f8"], "package_ndc": ["70000-0126-1", "70000-0126-2"], "is_original_packager": [true], "upc": ["0096295129496"], "unii": ["04JA59TNSJ"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0186-2024", "product_description": "Leader Nasal Decongestant PE (Phenylephrine HCl 10 mg), 18 Tablets per cartons, Distributed By Cardinal Health, Dublin, Ohio 43017.  NDC:  70000-0126-1", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch P125514", "more_code_info": ""}, {"status": "Completed", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204170"], "brand_name": ["ZOLPIDEM TARTRATE"], "generic_name": ["ZOLPIDEM TARTRATE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["47335-307", "47335-308"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ZOLPIDEM TARTRATE"], "rxcui": ["854880", "854894"], "spl_id": ["4a5c474b-e752-4d01-be37-a66e7c9bf62e"], "spl_set_id": ["0c64bc71-2e7f-4b15-a8e1-acb8de04395f"], "package_ndc": ["47335-307-88", "47335-307-13", "47335-308-88", "47335-308-13"], "is_original_packager": [true], "upc": ["0347335307887", "0347335308884"], "unii": ["WY6W63843K"]}, "product_type": "Drugs", "event_id": "93820", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0272-2024", "product_description": "Zolpidem Tartrate Extended-Release Tablets, USP 12.5mg, Rx Only, 100 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited, Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), INDIA, NDC 47335-308-88.", "product_quantity": "14,568 bottles", "reason_for_recall": "CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.", "recall_initiation_date": "20240118", "center_classification_date": "20240125", "report_date": "20240131", "code_info": "Lot #: DNE0893A Expires 07/31/2026"}, {"status": "Terminated", "city": "Wilmington", "state": "MA", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA090533"], "brand_name": ["ZENZEDI"], "generic_name": ["DEXTROAMPHETAMINE SULFATE"], "manufacturer_name": ["AZURITY PHARMACEUTICALS, INC."], "product_ndc": ["24338-850", "24338-851", "24338-852", "24338-853", "24338-854", "24338-855", "24338-856"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DEXTROAMPHETAMINE SULFATE"], "rxcui": ["884385", "884386", "884684", "1425337", "1425339", "1425847", "1425854", "1426251", "1426253", "1535451", "1535454", "1535456", "1535470", "1535472"], "spl_id": ["3777ce80-1fa3-6f52-e063-6294a90a3c51"], "spl_set_id": ["d6394df5-f2c9-47eb-b57e-f3e9cfd94f84"], "package_ndc": ["24338-850-03", "24338-851-03", "24338-852-03", "24338-853-03", "24338-854-03", "24338-855-03", "24338-856-03"], "is_original_packager": [true], "upc": ["0324338854037", "0324338852033", "0324338850039", "0324338853030", "0324338856031", "0324338851036"], "unii": ["JJ768O327N"]}, "product_type": "Drugs", "event_id": "93786", "recalling_firm": "Azurity Pharmaceuticals, Inc.", "address_1": "841 Woburn St", "address_2": "", "postal_code": "01887-3414", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide", "recall_number": "D-0323-2024", "product_description": "Zenzedi (Dextroamphetamine Sulfate) CII Tablets, USP, 30 mg, 30-count bottle, Rx only, Mfd. for: Arbor Pharmaceuticals, LLC., Atlanta, Georgia, 30328, NDC 24338-856-03", "product_quantity": "4,662 bottles", "reason_for_recall": "Labeling: Label Mix-up", "recall_initiation_date": "20240104", "center_classification_date": "20240212", "termination_date": "20240918", "report_date": "20240207", "code_info": "Lot # F230169A, Exp. 06/30/2025", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0181-2024", "product_description": "FIRST LANSOPRAZOLE PT 3MG/ML, 300ML, Rx Only, Distributed By:  CutisPharma, Inc., Woburn, MA 01801.  NDC: 65628-080-10", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 21025A", "more_code_info": ""}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0300-2024", "product_description": "Target brand High Performance Lubricant Eye Drops (Polyethylene glycol 400 0.4%, Propylene glycol 0.3%) a) 0.5 FL OZ (15mL) bottles (Single Pack) (NDC 11673-522-15) and b) 0.5 FL OZ (15 mL) bottles (Twin pack) (NDC 11673-522-30), Distributed by: Target Corporation Minneapolis, MN 55403", "product_quantity": "401,568 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Ongoing", "city": "Camarillo", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077538"], "brand_name": ["FLUTICASONE PROPIONATE"], "generic_name": ["FLUTICASONE PROPIONATE"], "manufacturer_name": ["Golden State Medical Supply, Inc."], "product_ndc": ["60429-195"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["NASAL"], "substance_name": ["FLUTICASONE PROPIONATE"], "rxcui": ["1797907"], "spl_id": ["288e6ace-95c2-732a-e063-6394a90a8a16"], "spl_set_id": ["db857d81-4b1e-42b8-972a-5bb8735d60f8"], "package_ndc": ["60429-195-15"], "is_original_packager": [true], "unii": ["O2GMZ0LF5W"]}, "product_type": "Drugs", "event_id": "94029", "recalling_firm": "Golden State Medical Supply Inc.", "address_1": "5187 Camino Ruiz", "address_2": "", "postal_code": "93012-8601", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0349-2024", "product_description": "Fluticasone Propionate Nasal Spray USP, 50 mcg per spray, 120 metered sprays, 16 g net fill, Rx only, Manufactured by: Apotek Inc., Toronto, Ontario, Cananda, Marketed by: GSMS Incorporated, Camarillo, CA, NDC 60429-195-15", "product_quantity": "59,712 bottles", "reason_for_recall": "CGMP Deviations:Suspected potential presence of Burkholderia cepacia complex", "recall_initiation_date": "20240214", "center_classification_date": "20240223", "report_date": "20240306", "code_info": "Lot #: TX5275, Exp. Date: 10/31/2026.", "more_code_info": ""}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211121"], "brand_name": ["NICARDIPINE HYDROCHLORIDE"], "generic_name": ["NICARDIPINE HYDROCHLORIDE"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-183"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["NICARDIPINE HYDROCHLORIDE"], "rxcui": ["858607"], "spl_id": ["4a19b4d6-9b86-4b20-befb-6c50a3898df4"], "spl_set_id": ["9f5d3050-9cdf-404f-ac0f-72399178959f"], "package_ndc": ["55150-183-02", "55150-183-11"], "is_original_packager": [true], "upc": ["0355150183111", "0355150183029"], "unii": ["K5BC5011K3"]}, "product_type": "Drugs", "event_id": "94073", "recalling_firm": "Eugia US LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0391-2024", "product_description": "Nicardipine Hydrochloride Injection, USP 25mg/mL (2.5 mg/mL) 10 mL vials, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520, NDC 55150-183-11", "product_quantity": "43,920 vials", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification for organic impurities", "recall_initiation_date": "20240220", "center_classification_date": "20240319", "report_date": "20240327", "code_info": "Lot #: 3NC22019, Exp. Date 2/24", "more_code_info": ""}, {"status": "Terminated", "city": "Brookhaven", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA210186"], "brand_name": ["OSELTAMIVIR PHOSPHATE"], "generic_name": ["OSELTAMIVIR PHOSPHATE"], "manufacturer_name": ["Amneal Pharmaceuticals NY LLC"], "product_ndc": ["69238-1273"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["OSELTAMIVIR PHOSPHATE"], "rxcui": ["1115698"], "spl_id": ["6d430d46-b7a8-4830-ab9f-7b0f234f6829"], "spl_set_id": ["c1a280d0-4ce9-494a-9924-eb5621ce3757"], "package_ndc": ["69238-1273-6"], "is_original_packager": [true], "upc": ["0369238127362"], "unii": ["4A3O49NGEZ"]}, "product_type": "Drugs", "event_id": "93959", "recalling_firm": "Amneal Pharmaceuticals of New York, LLC", "address_1": "50 Horseblock Rd", "address_2": "N/A", "postal_code": "11719-9509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0327-2024", "product_description": "Oseltamivir Phosphate for Oral Suspension 6mg/ml, 60 mL (reconstituted) bottle, RX only, Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. NDC# 69238-1273-6", "product_quantity": "46,037 Bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out-of-specification test results.", "recall_initiation_date": "20240213", "center_classification_date": "20240216", "termination_date": "20250214", "report_date": "20240228", "code_info": "Lot # BF22722A, Exp. 08/31/2024; BJ15122A, Exp. 09/30/2024"}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93710", "recalling_firm": "Denver Solutions, LLC DBA Leiters Health", "address_1": "13796 Compark Blvd", "address_2": "", "postal_code": "80112-7145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0282-2024", "product_description": "VANCOmycin HCl PF 1.5g added to 0.9% Sodium Chloride 250 mL IV bag, Item F3208, for IV use only; Leiters 13796 Compark Blvd Englewood, CO 80112; NDC 71449-029-68.", "product_quantity": "7,548 IV bags", "reason_for_recall": "Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.", "recall_initiation_date": "20231228", "center_classification_date": "20240129", "report_date": "20240207", "code_info": "Lot #: 2331140, Exp. Date 02/08/2024; 2331188, Exp. Date 02/15/2024; 2331261, Exp. Date 03/05/2024; 2331287, Exp. Date 03/14/2024.", "more_code_info": ""}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0247-2024", "product_description": "Secret, OUTLAST, Dry Spray, (Aluminum chlorohydrate 23.5%), Antiperspirant, Completely Clean, Topical spray can 3.8 oz (107 g), Dist. by: Procter & Gamble, Cincinnati, OH 45202. NDC: 69423-384-10, UPC 0 37000 74764 2", "product_quantity": "unknown", "reason_for_recall": "CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "All lots with expiry through September 2023"}, {"status": "Terminated", "city": "Durham", "state": "NC", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA203975"], "brand_name": ["ANORO ELLIPTA"], "generic_name": ["UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE"], "manufacturer_name": ["GlaxoSmithKline LLC"], "product_ndc": ["0173-0869"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["UMECLIDINIUM BROMIDE", "VILANTEROL TRIFENATATE"], "rxcui": ["1487519", "1487524", "1487527", "1487528"], "spl_id": ["90be6e26-9d2d-4b9d-8378-5e38c3076720"], "spl_set_id": ["2dbd0671-c565-40c5-bf0f-e324db26799c"], "package_ndc": ["0173-0869-10", "0173-0869-06", "0173-0869-61"], "is_original_packager": [true], "unii": ["7AN603V4JV", "40AHO2C6DG"]}, "product_type": "Drugs", "event_id": "93565", "recalling_firm": "GlaxoSmithKline LLC", "address_1": "410 Blackwell St", "address_2": "", "postal_code": "27701-3986", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA and Puerto Rico.", "recall_number": "D-0160-2024", "product_description": "ANORO ELLIPTA (umeclidinium and vilanterol inhalation powder) 62.5 mcg/25mcg.  1 inhaler contains 30 doses (60 blisters total), Rx Only, Manufactured by GlaxoSmithKline Durham, NC 27701. NDC 0173-0869-10", "product_quantity": "67,508 inhalers", "reason_for_recall": "Failed Release Testing: Coarse Particle Mass for umeclidinium Out of Specification", "recall_initiation_date": "20231212", "center_classification_date": "20231222", "termination_date": "20240912", "report_date": "20240103", "code_info": "Lot #:  7Y9S. Exp June 2025", "more_code_info": ""}, {"status": "Ongoing", "city": "New York", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["ANDA065031"], "brand_name": ["BLEOMYCIN"], "generic_name": ["BLEOMYCIN"], "manufacturer_name": ["Hospira, Inc."], "product_ndc": ["61703-323", "61703-332"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR", "INTRAPLEURAL", "INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["BLEOMYCIN SULFATE"], "rxcui": ["1726673", "1726676"], "spl_id": ["6615dbd2-3bb4-40b5-8599-aa46bc0bc488"], "spl_set_id": ["905e0984-2ce3-481c-b1a0-0ef0a616479a"], "package_ndc": ["61703-323-22", "61703-332-18"], "is_original_packager": [true], "unii": ["7DP3NTV15T"]}, "product_type": "Drugs", "event_id": "93693", "recalling_firm": "PFIZER", "address_1": "66 Hudson St", "address_2": "N/A", "postal_code": "10013", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA, Netherlands and Libya", "recall_number": "D-0261-2024", "product_description": "Bleomycin for Injection, USP, 15 units per vial, 1 single dose glass fliptop vial, Rx Only, Distributed by: Hospira, Inc., Lake Forest, IL 68045, NDC 61703-332-18", "product_quantity": "3,546 vials", "reason_for_recall": "Presence of particulate matter: glass", "recall_initiation_date": "20231221", "center_classification_date": "20240125", "report_date": "20240131", "code_info": "Lot #: BL12206A, Exp date 06/30/2024"}, {"status": "Terminated", "city": "Rosenberg", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93986", "recalling_firm": "Seatex LLC", "address_1": "445 Highway 36 N", "address_2": "", "postal_code": "77471-8756", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the US and Puerto Rico", "recall_number": "D-0357-2024", "product_description": "PROBLEND E3 Foaming Hand Sanitizer, All-In-One Foaming Hand Sanitizer & Cleanser, Seatex LLC, 445 TX Hwy 36 Rosenberg, TX 77471", "product_quantity": "274 cases", "reason_for_recall": "CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.", "recall_initiation_date": "20240219", "center_classification_date": "20240229", "termination_date": "20250815", "report_date": "20240306", "code_info": "Lot #: 265029, Exp. 03/27/2024; 273759, Exp. 11/29/2024.", "more_code_info": ""}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "94071", "recalling_firm": "Denver Solutions, LLC DBA Leiters Health", "address_1": "13796 Compark Blvd", "address_2": "", "postal_code": "80112-7145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0362-2024", "product_description": "Moxifloxacin 5mg/ml, 1 ml in a Single- Dose Vial, Rx Only, Leiters 13796 Compark Blvd, Englewood, CO 80112, NDC 71449-097-42", "product_quantity": "10,020 vials", "reason_for_recall": "Presence of Particulate Matter: glass vials from the manufacturer showed signs of glass delamination.", "recall_initiation_date": "20240220", "center_classification_date": "20240229", "report_date": "20240306", "code_info": "Lot #:2331123, Exp:28-Feb-24; 2331298, Exp: 24-Mar-24.", "more_code_info": ""}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0305-2024", "product_description": "CVS Health brand Mild Moderate Lubricating Eye Drops (Propylene glycol 400 0.25%), packaged in 0.5 FL OZ (15 mL) bottles, Distributed by: CVS Pharmacy Inc. One CVS Drive Woonsocket, RI 02895. NDC 76168-711-15", "product_quantity": "45,408 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93710", "recalling_firm": "Denver Solutions, LLC DBA Leiters Health", "address_1": "13796 Compark Blvd", "address_2": "", "postal_code": "80112-7145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0278-2024", "product_description": "FentaNYL citrate PF, 2500 mcg per 250 mL 0.9% Sodium Chloride (10 mcg per mL), Item F3342, for IV use only; Leiters 13796 Compark Blvd Englewood, CO 80112; NDC 71449-072-82.", "product_quantity": "13,920 IV bags", "reason_for_recall": "Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.", "recall_initiation_date": "20231228", "center_classification_date": "20240129", "report_date": "20240207", "code_info": "Lot #: 2330988, Exp. Date 01/31/2024; 2331058, Exp. Date 02/18/2024; 2331150, Exp. Date 03/10/2024; 2331231, Exp. Date 03/24/2024; 2331289, Exp. Date 03/30/2024.", "more_code_info": ""}, {"status": "Terminated", "city": "Irvine", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA085870"], "brand_name": ["POTASSIUM CHLORIDE"], "generic_name": ["POTASSIUM CHLORIDE"], "manufacturer_name": ["B. Braun Medical Inc."], "product_ndc": ["0264-1944"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["PARENTERAL"], "substance_name": ["POTASSIUM CHLORIDE"], "rxcui": ["204520"], "spl_id": ["95c83840-ae78-4210-8b5f-cf4120989811"], "spl_set_id": ["ab67b151-8368-4321-b562-bad5eff7b740"], "package_ndc": ["0264-1944-20"], "is_original_packager": [true], "unii": ["660YQ98I10"]}, "product_type": "Drugs", "event_id": "94184", "recalling_firm": "B. Braun Medical Inc", "address_1": "2525 Mcgaw Ave", "address_2": "N/A", "postal_code": "92614-5841", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0370-2024", "product_description": "Potassium Chloride for Injection Concentrate USP, 500 mEq/250 mL (2 mEq/mL), 250 mL Bag, Rx only, B. Braun Medical Inc., Bethlehem, PA 18018, NDC 0264-1944-20", "product_quantity": "22,752 bags", "reason_for_recall": "Lack of assurance of sterility: pinholes, within the blue label characters on the EXCEL bag, specifically within the dotted characters on the label, resulting in leaks.", "recall_initiation_date": "20240306", "center_classification_date": "20240308", "termination_date": "20250416", "report_date": "20240320", "code_info": "Lot #: J2S007, Exp: 12/31/2024; J3A115, Exp: 01/31/2025."}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA077091"], "brand_name": ["GLIMEPIRIDE"], "generic_name": ["GLIMEPIRIDE"], "manufacturer_name": ["Dr. Reddy's Laboratories Limited"], "product_ndc": ["55111-320", "55111-321", "55111-322"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["GLIMEPIRIDE"], "rxcui": ["199245", "199246", "199247"], "spl_id": ["e3d50334-9896-b2f9-a481-8383eb84b16a"], "spl_set_id": ["07ad4366-4b21-f633-49f3-c2b35f88168d"], "package_ndc": ["55111-320-30", "55111-320-01", "55111-320-05", "55111-320-79", "55111-320-78", "55111-321-30", "55111-321-01", "55111-321-05", "55111-321-79", "55111-321-78", "55111-322-30", "55111-322-01", "55111-322-05", "55111-322-79", "55111-322-78"], "is_original_packager": [true], "nui": ["N0000175608", "M0020795"], "pharm_class_epc": ["Sulfonylurea [EPC]"], "pharm_class_cs": ["Sulfonylurea Compounds [CS]"], "unii": ["6KY687524K"]}, "product_type": "Drugs", "event_id": "93833", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0313-2024", "product_description": "Glimepiride Tablets, USP 1mg, 500-count bottles, Rx Only, Mfd. By: Dr. Reddy's Laboratories Limited, Srikakulam-532 409 INDIA, NDC: 55111-320-05", "product_quantity": "14,425 bottles", "reason_for_recall": "Misprint on tablet", "recall_initiation_date": "20240118", "center_classification_date": "20240206", "report_date": "20240214", "code_info": "Lot: T2303609; Exp. 06/2026 Lot: T2303610; Exp. 06/2026", "more_code_info": ""}, {"status": "Completed", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA217519"], "brand_name": ["TOBRAMYCIN"], "generic_name": ["TOBRAMYCIN"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-470"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["TOBRAMYCIN SULFATE"], "rxcui": ["597823"], "spl_id": ["a4205ba6-2eba-4e4e-a2d4-b54447ed85f1"], "spl_set_id": ["c37c251f-92e9-40f0-8b0c-00d42875d776"], "package_ndc": ["55150-470-01", "55150-470-06"], "is_original_packager": [true], "upc": ["0355150470013"], "unii": ["HJT0RXD7JK"]}, "product_type": "Drugs", "event_id": "94081", "recalling_firm": "Eugia US LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "N/A", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0385-2024", "product_description": "Tobramycin for Injection, USP, 1.2 grams per Pharmacy Bulk Package, Rx Only, For Intravenous Use, PHARMACY BULK PACKAGE NOT FOR DIRECT INFUSION, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, Carton NDC 55150-470-06, Vial NDC 55150-470-01.", "product_quantity": "1160 VIALS", "reason_for_recall": "Failed Stability Specification: Water determination was found not complying with specification.", "recall_initiation_date": "20240222", "center_classification_date": "20240314", "report_date": "20240320", "code_info": "Lot #s: 3TB23001, 3TB23002, Exp. 04/30/2025."}, {"status": "Terminated", "city": "New York", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93946", "recalling_firm": "Super Chill Products", "address_1": "827 6th Ave", "address_2": "", "postal_code": "10001-6305", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the U.S.", "recall_number": "D-0393-2024", "product_description": "Neptune's Fix, Tianeptine Elixir, Fast Acting, 0.338 fl.oz. (10 mL) bottle, Distributed By Superchill Products, 827 6th Avenue, New York, New York 10001.", "product_quantity": "3,573 bottles", "reason_for_recall": "Marketed without an approved NDA/ANDA: Product contains tianeptine, a substance not FDA-approved for any medical use in the United States.", "recall_initiation_date": "20240205", "center_classification_date": "20240321", "termination_date": "20240820", "report_date": "20240327", "code_info": "All lots within expiry", "more_code_info": ""}, {"status": "Completed", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211858"], "brand_name": ["MESALAMINE"], "generic_name": ["MESALAMINE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["63304-175"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["MESALAMINE"], "rxcui": ["686429"], "spl_id": ["3f29d761-eab5-4f6b-a4f4-ffcc072648e3"], "spl_set_id": ["fd8b02de-7dfa-444d-a1f8-1436b578e0cb"], "package_ndc": ["63304-175-13"], "is_original_packager": [true], "nui": ["N0000175781", "M0000971"], "pharm_class_epc": ["Aminosalicylate [EPC]"], "pharm_class_cs": ["Aminosalicylic Acids [CS]"], "unii": ["4Q81I59GXC"]}, "product_type": "Drugs", "event_id": "93820", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0268-2024", "product_description": "Mesalamine Delayed-Release Tablets, USP 1.2 g per tablet, Rx Only, 120 Tablets per bottle, Once Daily, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited Survey No. 259/15, Dadra-396 191 (U.T. of D & NH), INDIA, NDC 63304-175-13.", "product_quantity": "10,690 bottles", "reason_for_recall": "CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.", "recall_initiation_date": "20240118", "center_classification_date": "20240125", "report_date": "20240131", "code_info": "Lot #s: DNE0875A Exp. 01/31/2025; DNE0876A, DNE0877A, DNE1080A, DNE1081A Exp. 02/28/2025; DNE1147A, DNE1148A Exp. 03/31/2025."}, {"status": "Ongoing", "city": "Thane", "state": "", "country": "India", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93885", "recalling_firm": "Brassica Pharma Pvt Ltd", "address_1": "Plot No. T-68, T 68 (Pt), T-63, Midc", "address_2": "Tarapur, Boisar", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0351-2024", "product_description": "Equate Lubricant Eye Ointment (Mineral Oil 42.5%, White Petrolatum 57.3%), Packaged in 3.5 gram tubes, Distributed by Walmart Inc., Bentonville, AR 72716, NDC 79903-026-35, UPC 681131395298", "product_quantity": "315,842 units", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20240130", "center_classification_date": "20240228", "report_date": "20240306", "code_info": "Lot #: A2E01, Exp. Date Apr-24; A2L05, Exp. Date Nov-24, A3B01, Exp. Date Jan-25;  A3C01, Exp. Date Feb-25", "more_code_info": ""}, {"status": "Terminated", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93500", "recalling_firm": "AnazaoHealth Corporation", "address_1": "7465 W Sunset Rd Ste 1200", "address_2": "", "postal_code": "89113-1944", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA.", "recall_number": "D-0204-2024", "product_description": "Thiamine HCl/Pyridoxine HCl 20 mg/mL /100mg/ml Injection Solution, 30mL Amber Glass Vial, Rx only, AnazaoHealth, 7465 W. Sunset Road, Las Vegas, NV, NDC 72682-8721-3.", "product_quantity": "3,363 vials", "reason_for_recall": "Presence of Particulate Matter.", "recall_initiation_date": "20231122", "center_classification_date": "20231226", "termination_date": "20250929", "report_date": "20240103", "code_info": "Lots: 508029, Exp: 12/14/23; 513191, Exp: 12/22/23; 524670, Exp: 01/12/24; 526254, Exp: 01/13/24; 530738, Exp: 01/19/23; 533570, Exp: 01/25/24; 538736, Exp: 02/03/24; 543220, Exp:02/16/24; 543508, Exp: 02/17/24; 545675, Exp: 02/22/24", "more_code_info": ""}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0252-2024", "product_description": "Old Spice, SWEAT DEFENSE  ULTIMATE CAPTAIN, Aluminum Chlorohydrate 23.5%, Anti-Perspirant, Topical spray can 3.8 OZ (107 g), Distr. by: Procter & Gamble, Cincinnati, OH 45202. NDC: 69423-385-10, UPC 0 37000 74947 9", "product_quantity": "unknown", "reason_for_recall": "CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "All lots with expiry through September 2023"}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93710", "recalling_firm": "Denver Solutions, LLC DBA Leiters Health", "address_1": "13796 Compark Blvd", "address_2": "", "postal_code": "80112-7145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0279-2024", "product_description": "PHENYLephrine HCl 20 mg per 250 mL 0.9% Sodium Chloride (80 mcg per mL), Item F3360, for IV use only; Leiters 13796 Compark Blvd Englewood, CO 80112; NDC 71449-148-94.", "product_quantity": "29,016 IV bags", "reason_for_recall": "Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.", "recall_initiation_date": "20231228", "center_classification_date": "20240129", "report_date": "20240207", "code_info": "Lot #: 2330993, Exp. Date 02/15/2024;  2331010, Exp. Date 02/10/2024; 2331055, Exp. Date 01/18/2024; 2331113, Exp. Date 02/26/2024; 2331181, Exp. Date 03/04/2024; 2331187, Exp. Date 03/23/2024; 2331266, Exp. Date 03/31/2024; 2331343, Exp. Date 04/01/2024; 2331349, Exp. Date 04/23/2024; 2331433, Exp. Date 05/05/2024.", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA200292"], "brand_name": ["DONEPEZIL HYDROCHLORIDE"], "generic_name": ["DONEPEZIL HYDROCHLORIDE"], "manufacturer_name": ["Solco Healthcare US, LLC"], "product_ndc": ["43547-275", "43547-276"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DONEPEZIL HYDROCHLORIDE"], "rxcui": ["997223", "997229"], "spl_id": ["dcfd9a94-e1bc-4b53-ae6f-0200ee714917"], "spl_set_id": ["042a59ea-131a-4806-b0f4-2f791d4414e2"], "package_ndc": ["43547-275-03", "43547-275-09", "43547-275-11", "43547-276-03", "43547-276-09", "43547-276-11"], "is_original_packager": [true], "upc": ["0343547276034", "0343547275037"], "unii": ["3O2T2PJ89D"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0176-2024", "product_description": "Donepezil HCl Tablets, 10 mg, 90 Tablets, Rx only, Distributed by: Solco Healthcare U.S. LLC, Hurracao, Puerto Rico 00791.  NDC: 43547-276-09", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 17616", "more_code_info": ""}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0251-2024", "product_description": "Old Spice, SWEAT DEFENSE PURE SPORT PLUS, (Aluminum Chlorohydrate 23.5%), Anti-Perspirant, Topical spray can, Net WT 3.8 oz (107 g) cans,  Distr. by: Procter & Gamble, Cincinnati, OH 45202. NDC: 69423-387-10, UPC 0 37000 72974 7", "product_quantity": "unknown", "reason_for_recall": "CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "All lots with expiry through September 2023"}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0308-2024", "product_description": "Multi-action Relief Drops (Polyvinyl alcohol 0.5%, Providone 0.6%, Tetrahydrozoline Hydrochloride 0.05%), packaged in 0.5 FL OZ (15 mL) bottles, Distributed by: Rite Aid 30 Hunter Lane, Camp Hill, PA 17011, NDC 11822-2254-3", "product_quantity": "9,216 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M013"], "brand_name": ["ASPIRIN"], "generic_name": ["ASPIRIN"], "manufacturer_name": ["Rugby Laboratories"], "product_ndc": ["0536-1234"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ASPIRIN"], "rxcui": ["308416"], "spl_id": ["8740c050-c1b4-4aba-b904-c950e0281a27"], "spl_set_id": ["63fcd93a-b1db-44ba-8f2b-055a7deb205d"], "package_ndc": ["0536-1234-41"], "is_original_packager": [true], "upc": ["0305361234416"], "nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "unii": ["R16CO5Y76E"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0170-2024", "product_description": "Low Dose ASPIRIN, 81 mg, 120 Enteric Coated Tablets, Distributed by: Rugby Lavoratories, 17177 N Laurel Park Drive, Suite 233, Livonia, MI 48152. NDC: 0536-1234-41", "product_quantity": "2 units", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch P126201", "more_code_info": ""}, {"status": "Ongoing", "city": "Massena", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "generic_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "manufacturer_name": ["CHAIN DRUG MARKETING ASSOCIATION INC."], "product_ndc": ["63868-605", "63868-676"], "product_type": ["HUMAN OTC DRUG"], "route": ["NASAL"], "substance_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "rxcui": ["1000990"], "spl_id": ["3446fcd3-f2b4-4f5f-b80e-f0600b7efc81"], "spl_set_id": ["c7b1f980-9b0d-4f63-a70d-fd366658f863"], "package_ndc": ["63868-605-01", "63868-676-01"], "is_original_packager": [true], "upc": ["0635515988439", "0635515988477", "635515988477"], "unii": ["K89MJ0S5VY"]}, "product_type": "Drugs", "event_id": "93708", "recalling_firm": "Seaway Pharma Inc.", "address_1": "5 County Route 42", "address_2": "N/A", "postal_code": "13662-1569", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MI, PA", "recall_number": "D-0216-2024", "product_description": "Quality Choice No Drip Extra Moisturizing Nasal Pump Mist Oxymetazoline hydrochloride 0.05%, 12 Hour Nasal Decongestant, 1 fl oz (30 mL) bottle, Distributed by C.D.M.A, Inc. 43157 W 9 Mile Rd. Novi, MI 48375, NDC# 63868-676-01, UPC 6-35515-98847-7.", "product_quantity": "7,992 bottles", "reason_for_recall": "CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.", "recall_initiation_date": "20231228", "center_classification_date": "20240104", "report_date": "20240110", "code_info": "Lot # SE23034, Exp 05/31/2026"}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M019"], "brand_name": ["SECRET ANTIPERSPIRANT"], "generic_name": ["ALUMINUM CHLOROHYDRATE"], "manufacturer_name": ["The Procter & Gamble Manufacturing Company"], "product_ndc": ["37000-134"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["ALUMINUM CHLOROHYDRATE"], "spl_id": ["28f210ab-96a1-6ed4-e063-6294a90ada78"], "spl_set_id": ["9f9720c0-a2d7-449c-b97c-19b980322b05"], "package_ndc": ["37000-134-11", "37000-134-17", "37000-134-01"], "is_original_packager": [true], "unii": ["HPN8MZW13M"], "upc": ["037000711094", "037000711087", "037000586906"]}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0253-2024", "product_description": "Secret, powder fresh, (Aluminum chlorohydrate 24%), Anti-Perspirant/Deodorant, Topical spray can Net Wt., (a) 4OZ (113g), NDC 37000-134-11, UPC 0 37000 71109 4, (b) 6OZ (170g),  NDC 37000-134-17, UPC 0 37000 71108 7; (c) twin pack-2 Topical spray cans, each can Net Wt. 6OZ (170g),  NDC: 37000-134-01, UPC 0 37000 58690 6; Dist. by: Procter & Gamble, Cincinnati, OH 45202,", "product_quantity": "unknown", "reason_for_recall": "CGMP Deviation; manufactured at the same facility where other lots were found to be contaminated with benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "All lots with expiry through September 2023"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0171-2024", "product_description": "Bumetanide Tablets, USP, 2 mg, 100 Tablets per bottle, Rx only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213 India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch AM211171", "more_code_info": ""}, {"status": "Terminated", "city": "Cincinnati", "state": "OH", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "89106", "recalling_firm": "The Procter & Gamble Company", "address_1": "1 Procter And Gamble Plz", "address_2": "N/A", "postal_code": "45202-3315", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide USA and Puerto Rico, Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, Guyana", "recall_number": "D-0244-2024", "product_description": "Secret, Dry Spray, Aluminum chlorohydrate 23.5%, Antiperspirant, Lavender, Topical spray can Net Wt 3.8 oz (107 g), Dist. by: Procter & Gamble, Cincinnati, OH 45202. NDC: 69423-383-10, UPC: 0 37000 72986 0", "product_quantity": "unknown", "reason_for_recall": "Chemical contamination: presence of benzene", "recall_initiation_date": "20211123", "center_classification_date": "20240117", "termination_date": "20241001", "report_date": "20240124", "code_info": "Lot #: 00221458SU, 00231458SA, Exp 12/31/2021; 10271458SR, Exp 12/31/2022."}, {"status": "Ongoing", "city": "Warren", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93702", "recalling_firm": "Haleon US Holdings LLC", "address_1": "184 Liberty Corner Rd", "address_2": "N/A", "postal_code": "07059-6796", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA nationwide", "recall_number": "D-0317-2024", "product_description": "Robitussin Honey CF Max Nighttime Adult (Acetaminophen 650 mg, Diphenhydramine HCl 25mg), 8 FL OZ (237 mL) bottle, Distributed by: GSK Consumer Healthcare, Warren, NJ 07059", "product_quantity": "21,900 bottles", "reason_for_recall": "Microbial Contamination of Non-Sterile Products", "recall_initiation_date": "20231226", "center_classification_date": "20240207", "report_date": "20240131", "code_info": "Lot#: T08740, T08742, Exp 06/30/2026"}, {"status": "Ongoing", "city": "Earth City", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077397"], "brand_name": ["SERTRALINE HYDROCHLORIDE"], "generic_name": ["SERTRALINE HYDROCHLORIDE"], "manufacturer_name": ["Legacy Pharmaceutical Packaging, LLC"], "product_ndc": ["68645-521", "68645-522", "68645-523"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SERTRALINE HYDROCHLORIDE"], "rxcui": ["312938", "312940", "312941"], "spl_id": ["33733144-b26c-b4a3-e063-6294a90ae049"], "spl_set_id": ["bd86b293-dab9-4d37-95eb-2bffca335d16"], "package_ndc": ["68645-521-54", "68645-522-54", "68645-523-54"], "original_packager_product_ndc": ["69097-833", "69097-834", "69097-835"], "upc": ["0368645522548", "0368645521541", "0368645523545"], "unii": ["UTI8907Y6X"]}, "product_type": "Drugs", "event_id": "93605", "recalling_firm": "Legacy Pharmaceutical Packaging LLC", "address_1": "13333 Lakefront Dr", "address_2": "", "postal_code": "63045-1514", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CA and AR", "recall_number": "D-0205-2024", "product_description": "Sertraline Tablets, USP 100 mg, 30 tablets per bottle, Distributed by: Wal-Mart, Bentonville, AR 72716, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, Packaged by: Legacy Pharmaceutical Packaging LLC., Earth City, MO 63045, NDC# 68645-523-54", "product_quantity": "161,664 bottles", "reason_for_recall": "CGMP Deviations: Inadequate line clearance which may result in a potential comingling of product.", "recall_initiation_date": "20231211", "center_classification_date": "20231226", "report_date": "20240103", "code_info": "Lot #: 222033, exp. date 08/31/2024", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040616"], "brand_name": ["WARFARIN SODIUM"], "generic_name": ["WARFARIN SODIUM"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0093-1712", "0093-1713", "0093-1714", "0093-1715", "0093-1716", "0093-1721", "0093-1718", "0093-1723", "0093-1720"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["WARFARIN SODIUM"], "rxcui": ["855288", "855296", "855302", "855312", "855318", "855324", "855332", "855338", "855344"], "spl_id": ["b8c33971-54b3-4971-bf7f-1bec66999a29"], "spl_set_id": ["0cbce382-9c88-4f58-ae0f-532a841e8f95"], "package_ndc": ["0093-1712-01", "0093-1712-10", "0093-1713-01", "0093-1713-10", "0093-1714-01", "0093-1714-10", "0093-1715-01", "0093-1716-01", "0093-1716-10", "0093-1721-01", "0093-1721-10", "0093-1718-01", "0093-1723-01", "0093-1720-01"], "is_original_packager": [true], "upc": ["0300931721013", "0300931713018", "0300931714015", "0300931723017", "0300931716019", "0300931715012"], "unii": ["6153CWM0CL"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0200-2024", "product_description": "Warfarin Sodium Tablets, USP, 2.5 mg, 100 Tablets per bottle, Rx only, Manufactured For: Teva Pharmaceuticals, Parsippany, NJ 07054.  NDC: 0093-1714-01", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 2169041", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA040197"], "brand_name": ["ESTRADIOL"], "generic_name": ["ESTRADIOL"], "manufacturer_name": ["Teva Pharmaceuticals USA, Inc."], "product_ndc": ["0555-0886", "0555-0899", "0555-0887"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ESTRADIOL"], "rxcui": ["197657", "197658", "197659"], "spl_id": ["3d020f63-1085-4e6f-9263-2933c29d5e16"], "spl_set_id": ["c4936878-1643-4e7f-9b0d-e4957935aef2"], "package_ndc": ["0555-0899-02", "0555-0886-02", "0555-0886-04", "0555-0887-02", "0555-0887-04"], "is_original_packager": [true], "nui": ["M0447348", "N0000175825", "N0000000100"], "pharm_class_cs": ["Estradiol Congeners [CS]"], "pharm_class_epc": ["Estrogen [EPC]"], "pharm_class_moa": ["Estrogen Receptor Agonists [MoA]"], "unii": ["4TI98Z838E"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0180-2024", "product_description": "ESTRADIOL TABLETS USP, 0.5MG 100 Tablets, Tx Only, Teva Pharmaceuticals USA, Inc., North Wales, PA 19454.  NDC: 0555-0899-02", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 100023687", "more_code_info": ""}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0296-2024", "product_description": "CVS brand Multi Action Relief Drops (Polyvinyl alcohol 0.5%, Povidone 0.6%, Tetrahydrozoline 0.05%) packaged in 0.5 FL OZ (15mL) bottles, Distributed by CVS Pharmacy Inc. One CVS Drive Woonsocket, RI 02895. NDC 76168-706-15", "product_quantity": "253,080 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Ongoing", "city": "Lompoc", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93831", "recalling_firm": "Den-Mat Holdings, LLC", "address_1": "1017 W Central Ave", "address_2": "", "postal_code": "93436-2701", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0287-2024", "product_description": "Hydrogen Peroxide Oral Rinse, Significantly Reduces Bacteria, Fresh Mint Flavor, Alcohol Free, a)16 fl. oz. (473 mL) bottle, NDC 59883-202-16, UPC 3 59883 00009 7); b) 64 fl. oz. (1.89 L) bottle, NDC 59883-202-64; c) 128 fl. oz. (1 gal) 3.78L bottle, NDC 59883-202-28, UPC 3 59883 00007 3), Manufactured by: Den-Mat Holdings, LLC, Lompoc, CA 93436.", "product_quantity": "10,103 units", "reason_for_recall": "CGMP Deviations: products may not conform to the labeled specifications.", "recall_initiation_date": "20240116", "center_classification_date": "20240131", "report_date": "20240207", "code_info": "Lot #: a) 2214500032, 2216700041, 2301900118, 2312600002, 2204800002, Exp. 02/05/2024; 2306100034, 2322000078, 2322200021 02/22/2024; 2318000026, Exp 02/24/2024; 2323000070, 2324400005, 2323300016, Exp 08/29/2025; 2324800079, Exp 08/30/2025; 2325800008, Exp 09/18/2025; 2328600011, 2328600032, 10/10/2025; 2324800123, Exp 10/11/2025; 2329700005, 2329700090, Exp 10/19/2025; 2330400003, Exp 10/25/2025; 2334100101, Exp 11/13/2025; 2335300019, 2335400038, Exp 12/19/2025.  b) 2212200014, Exp 02/22/2024; 2323300017, Exp 08/29/2025; 2324800124, Exp 09/18/2025. c) 2211100001, Exp 02/24/2024; 2330500009, Exp 10/25/2025; 2333200014, Exp12/19/2025.", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA204234"], "brand_name": ["DOXYCYCLINE"], "generic_name": ["DOXYCYCLINE"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-650", "68180-651", "68180-652"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["DOXYCYCLINE"], "rxcui": ["700408", "1649401", "1649990"], "spl_id": ["771f820a-2e1b-4a25-91cb-ba7a068abc70"], "spl_set_id": ["bcc65910-30d8-4807-ab61-607a56382924"], "package_ndc": ["68180-650-01", "68180-651-01", "68180-652-29", "68180-652-08"], "is_original_packager": [true], "upc": ["0368180652083", "0368180650010"], "nui": ["N0000175882", "N0000007948"], "pharm_class_epc": ["Tetracycline-class Drug [EPC]"], "pharm_class_cs": ["Tetracyclines [Chemical/Ingredient]"], "unii": ["N12000U13O"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0178-2024", "product_description": "Doxycycline Capsules, USP 100 mg, 50 Capsules, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202 Unite States; Manufactured by: Lupin Limited, Nagpur - 441 108, INDIA. NDC 68180-652-08", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch G104819", "more_code_info": ""}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211121"], "brand_name": ["NICARDIPINE HYDROCHLORIDE"], "generic_name": ["NICARDIPINE HYDROCHLORIDE"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-183"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["NICARDIPINE HYDROCHLORIDE"], "rxcui": ["858607"], "spl_id": ["9a7b2c37-aca0-445f-8078-f2ea7abe0dac"], "spl_set_id": ["dcd7d173-4d8e-4282-9edf-817711340e43"], "package_ndc": ["55150-183-01", "55150-183-10"], "is_original_packager": [true], "upc": ["0355150183012"], "unii": ["K5BC5011K3"]}, "product_type": "Drugs", "event_id": "94073", "recalling_firm": "Eugia US LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0390-2024", "product_description": "Nicardipine Hydrochloride Injection (2.5mg/mL), US, 25mg per 10mL, 10mL Vial, Rx only,  Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520 NDC 55150-183-10", "product_quantity": "335,940 vials", "reason_for_recall": "Failed Impurities/Degradation Specifications: Out of specification for organic impurities", "recall_initiation_date": "20240220", "center_classification_date": "20240319", "report_date": "20240327", "code_info": "Lot #: 3NC23002, Exp. Date 7/24; 3NC22013, 3NC22014, 3NC22015, 3NC22016,  3NC22017, 3NC22018, Exp. Date 2/24; 3NC22020, Exp. Date 3/24", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA208891"], "brand_name": ["WIXELA INHUB"], "generic_name": ["FLUTICASONE PROPIONATE AND SALMETEROL"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "product_ndc": ["0378-9320", "0378-9321", "0378-9322"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["FLUTICASONE PROPIONATE", "SALMETEROL XINAFOATE"], "rxcui": ["896184", "896209", "896228", "2110510", "2110513", "2110516"], "spl_id": ["03d33612-03b4-4a2c-ba86-47816db363ce"], "spl_set_id": ["3beef422-8a07-4a45-9ba6-414511e4b7e2"], "package_ndc": ["0378-9320-32", "0378-9321-32", "0378-9322-32"], "is_original_packager": [true], "unii": ["6EW8Q962A5", "O2GMZ0LF5W"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0202-2024", "product_description": "Inhub Wixela (fluticasone propionate and salmeterol inhalation powder, USP) 500/50MCG,  60 Doses of Inhalation Powder, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505.  NDC: 0378-9320-32", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 62002532", "more_code_info": ""}, {"status": "Terminated", "city": "Rosenberg", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93986", "recalling_firm": "Seatex LLC", "address_1": "445 Highway 36 N", "address_2": "", "postal_code": "77471-8756", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the US and Puerto Rico", "recall_number": "D-0360-2024", "product_description": "PROBLEND Hand Sanitizer, Refreshing Gel Hand Sanitizer, Ethanol 70% v/v Antiseptic, mountain spring scent, 1250 mL cases, Seatex LLC, 445 TX Hwy 36 Rosenberg, YX 77471", "product_quantity": "480 cases", "reason_for_recall": "CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.", "recall_initiation_date": "20240219", "center_classification_date": "20240229", "termination_date": "20250815", "report_date": "20240306", "code_info": "Lot #: 266029, Exp. 03/27/2024.", "more_code_info": ""}, {"status": "Ongoing", "city": "Rochester", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA204485"], "brand_name": ["VASOSTRICT"], "generic_name": ["VASOPRESSIN"], "manufacturer_name": ["ENDO USA, Inc."], "product_ndc": ["42023-164", "42023-190", "42023-219", "42023-220", "42023-237", "42023-268"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["VASOPRESSIN, UNSPECIFIED"], "rxcui": ["313578", "1593738", "2103182", "2103184", "2399907", "2399909", "2399913", "2399915", "2591428", "2591431", "2670680", "2670683"], "spl_id": ["ae4fb2c4-03cd-49b1-8d50-b3ec733478f4"], "spl_set_id": ["b1147beb-743e-4c62-8927-91192447f8b8"], "package_ndc": ["42023-164-01", "42023-164-25", "42023-164-10", "42023-190-01", "42023-219-01", "42023-219-10", "42023-220-01", "42023-220-10", "42023-237-01", "42023-237-10", "42023-268-01", "42023-268-10"], "is_original_packager": [true], "upc": ["0342023157010"], "unii": ["Y87Y826H08"]}, "product_type": "Drugs", "event_id": "93805", "recalling_firm": "Par Sterile Products LLC", "address_1": "870 Parkdale Rd", "address_2": "N/A", "postal_code": "48307-1740", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0232-2024", "product_description": "Vasostrict (vasopressin in 5% Dextrose) Injection, 20 units per 100 mL (0.2 units per mL), 100 mL x 10 Single Dose Vials per carton, Ready to Use, For Intravenous Infusion, Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977.  NDC: 42023-237-10", "product_quantity": "1721 cartons", "reason_for_recall": "Superpotent Drug: Assay from the 3-month and 6-month stability intervals exceeded the upper specification limit.", "recall_initiation_date": "20240111", "center_classification_date": "20240116", "report_date": "20240124", "code_info": "Lot # 66702; Exp. 02/2025"}, {"status": "Completed", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA207008"], "brand_name": ["CINACALCET"], "generic_name": ["CINACALCET"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["47335-379", "47335-380", "47335-600"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CINACALCET HYDROCHLORIDE"], "rxcui": ["432400", "432401", "432402"], "spl_id": ["fb601aec-aba6-4bec-a98d-51e556fef95c"], "spl_set_id": ["092553cf-1bcd-4c19-9adf-b46f2bda5c9e"], "package_ndc": ["47335-379-83", "47335-380-83", "47335-600-83"], "is_original_packager": [true], "upc": ["0347335600834"], "unii": ["1K860WSG25"]}, "product_type": "Drugs", "event_id": "93820", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0263-2024", "product_description": "Cinacalcet Tablets 60mg, Rx Only, 30 Tablets per bottle, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Limited Survey No. 259/15, Dadra-396 191 (U.T. of D & NH), India, NDC 47335-380-83.", "product_quantity": "1,728 bottles", "reason_for_recall": "CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.", "recall_initiation_date": "20240118", "center_classification_date": "20240125", "report_date": "20240131", "code_info": "Lot #: DNE0702A, Exp. 06/30/2026"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077538"], "brand_name": ["FLUTICASONE PROPIONATE"], "generic_name": ["FLUTICASONE PROPIONATE"], "manufacturer_name": ["Apotex Corp."], "product_ndc": ["60505-0829"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["NASAL"], "substance_name": ["FLUTICASONE PROPIONATE"], "rxcui": ["1797907"], "spl_id": ["de4b94c3-9864-33f5-8afe-ec494562de52"], "spl_set_id": ["3830675d-b45e-fc97-1f73-674b1fc38c80"], "package_ndc": ["60505-0829-1"], "is_original_packager": [true], "unii": ["O2GMZ0LF5W"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0182-2024", "product_description": "Fluticasone Propionate Nasal Spray USP, 50MCG per spray, 16 g net fill weight, 120 Metered Sprays, For Intranasal Use Only, Rx Only, Manufactured for: Apotext Corp., Weston, FL 33326.  NDC: 60505-0829-1", "product_quantity": "6 units", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch TE9159, TE8156", "more_code_info": ""}, {"status": "Completed", "city": "Mooresville", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93869", "recalling_firm": "Bestco LLC", "address_1": "288 Mazeppa Rd", "address_2": "N/A", "postal_code": "28115-7928", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0329-2024", "product_description": "Meijer Cherry Cough Drops, Menthol cough suppressant/Oral Anesthetic, 200 drops per bag, item number 20000345, Bestco, 288 Mazeppa Road, Mooresville, NC 28115", "product_quantity": "16 cases/4 pack each", "reason_for_recall": "CGMP Deviations: Potential Glass and Silicone particulates in product", "recall_initiation_date": "20240119", "center_classification_date": "20240216", "report_date": "20240228", "code_info": "100042236, Exp 12/31/2026"}, {"status": "Completed", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA208066"], "brand_name": ["LURASIDONE HYDROCHLORIDE"], "generic_name": ["LURASIDONE HYDROCHLORIDE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["47335-578", "47335-684", "47335-639", "47335-685", "47335-579"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LURASIDONE HYDROCHLORIDE"], "rxcui": ["1040031", "1040041", "1235247", "1297278", "1431235"], "spl_id": ["2ebf334e-6f66-4ef7-b0ca-9d21ccb3165e"], "spl_set_id": ["6d97d871-66d3-4ed8-bbc5-0620e9f69ae5"], "package_ndc": ["47335-578-83", "47335-578-81", "47335-578-13", "47335-684-83", "47335-684-81", "47335-684-13", "47335-639-83", "47335-639-81", "47335-639-13", "47335-685-83", "47335-685-81", "47335-685-13", "47335-579-83", "47335-579-81", "47335-579-13"], "is_original_packager": [true], "unii": ["O0P4I5851I"]}, "product_type": "Drugs", "event_id": "93820", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0267-2024", "product_description": "Lurasidone Hydrochloride Tablets 120mg, Rx Only, 30 Tablets per bottle, Distributed by:  Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries Ltd., Survey No. 259/15, Dadra-396 191(U.T. of D & NH), INDIA, NDC 47335-579-83.", "product_quantity": "9,408 bottles", "reason_for_recall": "CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.", "recall_initiation_date": "20240118", "center_classification_date": "20240125", "report_date": "20240131", "code_info": "Lot #s: DNE0621A Exp. 11/30/2024, DNE0815A Exp. 12/31/2024"}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0294-2024", "product_description": "CVS Health brand Lubricating Gel Drops (Polyethylene glycol 400 0.4% and Propylene glycol 0.3%), packaged in 0.33 FL OZ (10 mL) bottles, Distributed by: CVS Pharmacy Inc. One CVS Drive Woonsocket, RI 02895. NDC 76168-712-10", "product_quantity": "110,832 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0310-2024", "product_description": "Rugby brand Lubricating Tears Eye Drops (Dextran 70 0.1%, Hypromellose 2910 0.3%), packaged in 0.5 FL OZ (15 mL) bottles, Distributed by: Rugby Laboratories, Livonia, MI 48152, NDC 0536-1282-94", "product_quantity": "56,520 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Ongoing", "city": "Westport", "state": "CT", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "89601", "recalling_firm": "TCP HRB ACQUISITON LLC", "address_1": "270 Saugatuck Ave", "address_2": "", "postal_code": "06880-6431", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the US and Canada", "recall_number": "D-0209-2024", "product_description": "Sure Regular Antiperspirant Deodorant Aerosol (Aluminum Chlorohydrate 10%), packaged in 6 oz (170 g) aerosol cans, Distributed by Idelle Labs, Ltd., El Paso, TX 79912, NDC 41595-5518-06", "product_quantity": "5.4 million", "reason_for_recall": "Chemical contamination: Presence of benzene", "recall_initiation_date": "20220216", "center_classification_date": "20231228", "report_date": "20240103", "code_info": "All lots, expiry on or before August 2023", "more_code_info": ""}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090034"], "brand_name": ["RIFAMPIN"], "generic_name": ["RIFAMPIN"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-658", "68180-659"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["RIFAMPIN"], "rxcui": ["198201", "198202"], "spl_id": ["3c9f0101-dcf8-487e-985e-09c56746d3a1"], "spl_set_id": ["b56004f0-f23d-47f6-80c7-39884fccbccc"], "package_ndc": ["68180-658-06", "68180-658-01", "68180-659-06", "68180-659-07", "68180-659-01"], "is_original_packager": [true], "nui": ["N0000175500", "M0019113"], "pharm_class_epc": ["Rifamycin Antibacterial [EPC]"], "pharm_class_cs": ["Rifamycins [CS]"], "unii": ["VJT6J7R4TR"]}, "product_type": "Drugs", "event_id": "93753", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to 32 Wholesale/distributor accounts who further distributed the product to 156 distribution sites.", "recall_number": "D-0283-2024", "product_description": "Rifampin Capsules USP 150mg, 30-count bottle, Rx Only, Manufactured for:   Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured Lupin Limited, Aurangabad 431 210 INDIA, NDC 68180-658-06", "product_quantity": "15,576 Bottles", "reason_for_recall": "Subpotent Drug and Failed Impurities/Degradation Specifications", "recall_initiation_date": "20240105", "center_classification_date": "20240130", "termination_date": "20240827", "report_date": "20240207", "code_info": "A200816 exp 1/2024 A201248 exp 3/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Englewood", "state": "CO", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93710", "recalling_firm": "Denver Solutions, LLC DBA Leiters Health", "address_1": "13796 Compark Blvd", "address_2": "", "postal_code": "80112-7145", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0280-2024", "product_description": "PHENYLephrine HCl 40 mg per 250 mL 0.9% Sodium Chloride (160 mcg per mL), Item F3352, for IV use only; Leiters 13796 Compark Blvd Englewood, CO 80112; NDC 71449-150-82.", "product_quantity": "12,564 IV bags", "reason_for_recall": "Superpotent Drug: semi-automated IV bag filling system can malfunction and provide a double dose of drug product to IV bags.", "recall_initiation_date": "20231228", "center_classification_date": "20240129", "report_date": "20240207", "code_info": "Lot #: 2330939, Exp. Date 01/30/2024; 2331032, Exp. Date 02/03/2024; 2331112, Exp. Date 03/19/2024; 2331190, Exp. Date 03/26/2024; 2331429, Exp. Date 04/28/2024.", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077912"], "brand_name": ["LISINOPRIL AND HYDROCHLOROTHIAZIDE"], "generic_name": ["LISINOPRIL AND HYDROCHLOROTHIAZIDE"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-518", "68180-519", "68180-520"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["HYDROCHLOROTHIAZIDE", "LISINOPRIL"], "rxcui": ["197885", "197886", "197887"], "spl_id": ["1474b42e-df82-41d5-9cbd-ebe3c45dcc9d"], "spl_set_id": ["515f735c-5dba-43d9-8a58-97a319cafd56"], "package_ndc": ["68180-518-02", "68180-518-01", "68180-518-30", "68180-519-30", "68180-519-01", "68180-519-02", "68180-520-02", "68180-520-30", "68180-520-01"], "is_original_packager": [true], "nui": ["N0000175359", "N0000175419", "M0471776"], "pharm_class_pe": ["Increased Diuresis [PE]"], "pharm_class_epc": ["Thiazide Diuretic [EPC]"], "pharm_class_cs": ["Thiazides [CS]"], "unii": ["0J48LPH2TH", "E7199S1YWR"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0188-2024", "product_description": "Lisinopril and Hydrochlorothiazide Tablets USP, 10mg/12.5mg, Rx only, 100 Tablets per bottles, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202; Manufactured by: Lupin Limited, Nagpur-441 108, India.  NDC:   68180-518-01", "product_quantity": "2 units", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch Q101699, Q101981", "more_code_info": ""}, {"status": "Ongoing", "city": "East Windsor", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211930"], "brand_name": ["METHYLPREDNISOLONE ACETATE"], "generic_name": ["METHYLPREDNISOLONE ACETATE"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-313", "55150-314"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRA-ARTICULAR", "INTRALESIONAL", "INTRAMUSCULAR", "SOFT TISSUE"], "substance_name": ["METHYLPREDNISOLONE ACETATE"], "rxcui": ["1358610", "1358617"], "spl_id": ["a0cbcdb5-f657-49f7-8f86-cc5959d69db0"], "spl_set_id": ["a0cbcdb5-f657-49f7-8f86-cc5959d69db0"], "package_ndc": ["55150-313-25", "55150-313-01", "55150-314-25", "55150-314-01"], "is_original_packager": [true], "upc": ["0355150313013", "0355150314010"], "unii": ["43502P7F0P"]}, "product_type": "Drugs", "event_id": "94075", "recalling_firm": "Eugia US LLC", "address_1": "279 Princeton Hightstown Rd", "address_2": "", "postal_code": "08520-1401", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "OH, TN, LA, MS", "recall_number": "D-0366-2024", "product_description": "Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, Rx only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ 08520, NDC 55150-314-01", "product_quantity": "10,080 vials", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20240220", "center_classification_date": "20240304", "report_date": "20240313", "code_info": "Lot #: 3MA23001, 3MA23002, 3MA23003, Exp 3/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Massena", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M012"], "brand_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "generic_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "manufacturer_name": ["CHAIN DRUG MARKETING ASSOCIATION INC."], "product_ndc": ["63868-607"], "product_type": ["HUMAN OTC DRUG"], "route": ["NASAL"], "substance_name": ["OXYMETAZOLINE HYDROCHLORIDE"], "rxcui": ["1000990"], "spl_id": ["b20bf193-c444-44c8-8fea-012de3f835f4"], "spl_set_id": ["2ee2b332-9b85-45a6-b242-3f0ebfbd08a6"], "package_ndc": ["63868-607-01"], "is_original_packager": [true], "upc": ["0635515988446", "635515988439", "840986035098"], "unii": ["K89MJ0S5VY"]}, "product_type": "Drugs", "event_id": "93708", "recalling_firm": "Seaway Pharma Inc.", "address_1": "5 County Route 42", "address_2": "N/A", "postal_code": "13662-1569", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "MI, PA", "recall_number": "D-0214-2024", "product_description": "Nasal Spray Original No Drip Oxymetazoline HCl Nasal Solution, 12 Hour Pump Mist, 1 FL oz. (30 mL) bottle, a) Quality Choice, Distributed by C.D.M.A. Inc., 43157 W 9 Mile Rd, Novi, MI 48375, NDC# 63868-607-01, UPC 6-35515-98843-9, b) Premier Value, Distributed by: Pharmacy Value Alliance, LLC, 407 East Lancaster Avenue, Wayne, PA 19087 UPC 8-40986-03509-8.", "product_quantity": "7,992 bottles", "reason_for_recall": "CGMP Deviations: Firm reported possible microbial contamination in the purified water used in the manufacturing of the products. No contamination was found in the final products.", "recall_initiation_date": "20231228", "center_classification_date": "20240104", "report_date": "20240110", "code_info": "Lot # SD23032, Exp 04/30/2026"}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {"application_number": ["M018"], "brand_name": ["EYES IRRITATION RELIEF"], "generic_name": ["POLYVINYL ALCOHOL AND POVIDONE AND TETRAHYDROZOLINE HYDROCHLORIDE"], "manufacturer_name": ["CARDINAL HEALTH 110, LLC. DBA LEADER"], "product_ndc": ["70000-0087"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["POLYVINYL ALCOHOL, UNSPECIFIED", "POVIDONE, UNSPECIFIED", "TETRAHYDROZOLINE HYDROCHLORIDE"], "rxcui": ["1235569"], "spl_id": ["aaaabf8c-8ca5-4fe3-8e21-ba270c7f3991"], "spl_set_id": ["bd2608c6-ffdf-352a-e053-2995a90a26a8"], "package_ndc": ["70000-0087-1"], "is_original_packager": [true], "unii": ["532B59J990", "FZ989GH94E", "0YZT43HS7D"]}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0297-2024", "product_description": "Leader brand Eye Irritation Relief (Polyvinyl alcohol 0.5%, Povidone 0.6%, Tetrahydrozoline 0.05%), packaged in 0.5 FL OZ (15 mL) bottles, Cardinal Health Dublin, Ohio 43017, NDC 70000-0087-1", "product_quantity": "10,944 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Ongoing", "city": "East Hampton", "state": "NY", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93510", "recalling_firm": "Meta Herbal", "address_1": "33 Cordwood Ln", "address_2": "", "postal_code": "11937-5201", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA. Product was sold via Amazon's Marketplace.", "recall_number": "D-0206-2024", "product_description": "Magnum XXL 9800, 2000 mg per capsule, 1 capsule per blister pack, Distributed by Magnum Los Angelas CA. UPC 6 45759 99300 7. Amazon's ASIN# B07P7ZH797, B07P94J3ZT, B07P6VK6N3, B076HNPZZZ", "product_quantity": "500 blister packs", "reason_for_recall": "Marketed without an approved NDA/ANDA: Magnum XXL found to contain undeclared active pharmaceutical ingredient (API) - Sildenafil.", "recall_initiation_date": "20231129", "center_classification_date": "20231227", "report_date": "20240103", "code_info": "All Lots", "more_code_info": ""}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA090034"], "brand_name": ["RIFAMPIN"], "generic_name": ["RIFAMPIN"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["60687-575", "60687-586"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["RIFAMPIN"], "rxcui": ["198201", "198202"], "spl_id": ["3cd2b6a6-7724-43a5-e063-6294a90a3058"], "spl_set_id": ["50f706f9-5003-4e15-bece-85b6213b1f5c"], "package_ndc": ["60687-586-11", "60687-586-01", "60687-575-11", "60687-575-21"], "original_packager_product_ndc": ["68180-659", "68180-658"], "nui": ["N0000175500", "M0019113"], "pharm_class_epc": ["Rifamycin Antibacterial [EPC]"], "pharm_class_cs": ["Rifamycins [CS]"], "unii": ["VJT6J7R4TR"]}, "product_type": "Drugs", "event_id": "93851", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0285-2024", "product_description": "Rifampin Capsules USP, 150 mg, 30 Capsules (3 x 10) unit doses per carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC Carton: 60687-575-21; NDC Unit Dose: 60687-575-11", "product_quantity": "1,568 cartons", "reason_for_recall": "Failed Impurities/Degradation Specification.", "recall_initiation_date": "20240111", "center_classification_date": "20240130", "termination_date": "20240930", "report_date": "20240207", "code_info": "Lot #: 1008111, Exp. Date 01/31/2024", "more_code_info": ""}, {"status": "Ongoing", "city": "Navi Mumbai", "state": "", "country": "India", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "93357", "recalling_firm": "Kilitch Healthcare India Limited", "address_1": "R - 904 905 T T C Industrial Road", "address_2": "", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0301-2024", "product_description": "Leader brand Lubricant Eye Drops (Propylene glycol Eye Drops 0.6%), packaged in 0.33 FL OZ (10 mL) bottles, Cardinal Health Dublin, Ohio 43017, NDC 70000-0587-1", "product_quantity": "14,784 bottles", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20231113", "center_classification_date": "20240205", "report_date": "20240214", "code_info": "All lots", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077553"], "brand_name": ["TERCONAZOLE"], "generic_name": ["TERCONAZOLE"], "manufacturer_name": ["Cosette Pharmaceuticals, Inc."], "product_ndc": ["0713-0552"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["VAGINAL"], "substance_name": ["TERCONAZOLE"], "rxcui": ["198245"], "spl_id": ["ee20ae91-d9b6-6f7f-e053-2a95a90a3171"], "spl_set_id": ["38cd1718-6b3c-415d-a17f-7b399adb0ba2"], "package_ndc": ["0713-0552-73"], "is_original_packager": [true], "nui": ["N0000175487", "M0002083"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_cs": ["Azoles [CS]"], "unii": ["0KJ2VE664U"]}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0198-2024", "product_description": "Terconazole Vaginal Suppositories, 80 mg, 3 Suppositories with Vaginal Applicator, Rx only,  Manufactured by: Cosette Pharmaceuticals, Inc., 111 Coolidge Street, South Plainfield, NJ 07080.  NDC: 0713-0552-73", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 1014228A", "more_code_info": ""}, {"status": "Completed", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205467"], "brand_name": ["FEBUXOSTAT"], "generic_name": ["FEBUXOSTAT"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["60687-538"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FEBUXOSTAT"], "rxcui": ["834235"], "spl_id": ["102d1826-981f-0ebc-e063-6294a90a4acc"], "spl_set_id": ["14f80ad5-37cc-4672-9caa-2dd2f469af0a"], "package_ndc": ["60687-538-11", "60687-538-21"], "original_packager_product_ndc": ["47335-721"], "nui": ["N0000175698", "N0000000206"], "pharm_class_epc": ["Xanthine Oxidase Inhibitor [EPC]"], "pharm_class_moa": ["Xanthine Oxidase Inhibitors [MoA]"], "unii": ["101V0R1N2E"]}, "product_type": "Drugs", "event_id": "93918", "recalling_firm": "Amerisource Health Services LLC", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0314-2024", "product_description": "Febuxostat Tablets, 40 mg, 30 Tablets (3 x 10) per carton, Rx only, Distributed by: American Health Packaging, Columbus, Ohio 43217.  NDC Carton: 60687-538-21, NDC Unit dose 60687-538-11", "product_quantity": "1,932 cartons", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20240125", "center_classification_date": "20240206", "report_date": "20240214", "code_info": "Lot # 1015033, exp. 06/30/2025; 1016409, exp. 08/31/2025", "more_code_info": ""}, {"status": "Ongoing", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA205467"], "brand_name": ["FEBUXOSTAT"], "generic_name": ["FEBUXOSTAT"], "manufacturer_name": ["NorthStar RxLLC"], "product_ndc": ["16714-059", "16714-060"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FEBUXOSTAT"], "rxcui": ["834235", "834241"], "spl_id": ["0284b7a5-7a1f-4e37-9883-b7bdba68c42b"], "spl_set_id": ["ad40e0f6-850c-429a-87fc-f1eb2361e962"], "package_ndc": ["16714-059-01", "16714-060-01"], "is_original_packager": [true], "upc": ["0316714060019"], "nui": ["N0000175698", "N0000000206"], "pharm_class_epc": ["Xanthine Oxidase Inhibitor [EPC]"], "pharm_class_moa": ["Xanthine Oxidase Inhibitors [MoA]"], "unii": ["101V0R1N2E"]}, "product_type": "Drugs", "event_id": "94142", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "N/A", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0369-2024", "product_description": "Febuxostat Tablets 80mg, RX Only, 30 Tablets per bottle, NorthStarx, Manufactured for: Northstar Rx LLC., Memphis, TN 38141, Manufactured by: Sun Pharmaceutical Industries Limited Survey No. 259/15, Dadra-396 191, (U.T. of D & NH), India, NDC 16714-060-01.", "product_quantity": "7,488 bottles", "reason_for_recall": "CGMP Deviations: Microbial contamination was reported in stagnant water in the duct of the manufacturing equipment.", "recall_initiation_date": "20240304", "center_classification_date": "20240308", "report_date": "20240320", "code_info": "Lot #: DNE0894A, Exp 07/31/2025"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "89450", "recalling_firm": "CARDINAL HEALTHCARE", "address_1": "7200 Cardinal Pl W", "address_2": "", "postal_code": "43017-1094", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0189-2024", "product_description": "Lithium Carbonate Extended-Release Tablets, USP, 300 mg, 100 Tablets per bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505.  NDC: 0378-1300-01", "product_quantity": "1 unit", "reason_for_recall": "CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage conditions.", "recall_initiation_date": "20220126", "center_classification_date": "20231226", "termination_date": "20240929", "report_date": "20240103", "code_info": "Batch 3138326", "more_code_info": ""}, {"status": "Ongoing", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA211890"], "brand_name": ["IBUPROFEN AND FAMOTIDINE"], "generic_name": ["IBUPROFEN AND FAMOTIDINE"], "manufacturer_name": ["Ascend Laboratories, LLC"], "product_ndc": ["67877-626"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["FAMOTIDINE", "IBUPROFEN"], "rxcui": ["1100066"], "spl_id": ["5107e958-bc99-4832-931e-4c47e25ec6eb"], "spl_set_id": ["4493d4cd-ca8e-4b0a-9b65-b75e55bf8b9e"], "package_ndc": ["67877-626-90", "67877-626-01", "67877-626-05", "67877-626-06"], "is_original_packager": [true], "upc": ["0367877626901", "0367877626062"], "nui": ["N0000000151", "N0000175784", "N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Histamine H2 Receptor Antagonists [MoA]", "Cyclooxygenase Inhibitors [MoA]"], "pharm_class_epc": ["Histamine-2 Receptor Antagonist [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "unii": ["5QZO15J2Z8", "WK2XYI10QM"]}, "product_type": "Drugs", "event_id": "93701", "recalling_firm": "Ascend Laboratories, LLC", "address_1": "339 Jefferson Rd Ste 101", "address_2": "N/A", "postal_code": "07054-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0237-2024", "product_description": "Ibuprofen and Famotidine Tablets 800mg/26.6mg, Rx Only, 90 Tablets per Bottle, manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC., Parsippany, NJ 07054, NDC 67877-626-90", "product_quantity": "3,288 bottles", "reason_for_recall": "Presence of Foreign Tablet/Capsule: A stray Rasagiline Mesylate 1 mg tablet was discovered in an unopened bottle of Ibuprofen and Famotidine.", "recall_initiation_date": "20231229", "center_classification_date": "20240117", "report_date": "20240124", "code_info": "23140190, Exp. Date 12/31/2024"}, {"status": "Completed", "city": "Mooresville", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "93869", "recalling_firm": "Bestco LLC", "address_1": "288 Mazeppa Rd", "address_2": "N/A", "postal_code": "28115-7928", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0330-2024", "product_description": "Kroger Cherry Cough Drops, Menthol cough suppressant/Oral Anesthetic, 200 drops per bag, item number 20000064, Bestco, 288 Mazeppa Road, Mooresville, NC 28115", "product_quantity": "21 cases/4 pack each", "reason_for_recall": "CGMP Deviations: Potential Glass and Silicone particulates in product", "recall_initiation_date": "20240119", "center_classification_date": "20240216", "report_date": "20240228", "code_info": "100042238, Exp 12/31/2026"}, {"status": "Terminated", "city": "Richmond", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA206206"], "brand_name": ["ROCURONIUM BROMIDE"], "generic_name": ["ROCURONIUM BROMIDE"], "manufacturer_name": ["Eugia US LLC"], "product_ndc": ["55150-225", "55150-226"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS"], "substance_name": ["ROCURONIUM BROMIDE"], "rxcui": ["1234995"], "spl_id": ["256e0877-720b-40a2-be71-d503e8b860ab"], "spl_set_id": ["116385ea-69fc-4f44-b463-6210291032df"], "package_ndc": ["55150-225-05", "55150-226-10"], "is_original_packager": [true], "upc": ["0355150226108"], "unii": ["I65MW4OFHZ"]}, "product_type": "Drugs", "event_id": "93935", "recalling_firm": "Mckesson Medical-Surgical Inc. Corporate Office", "address_1": "9954 Maryland Drive", "address_2": "Deep Run Iii Ste. 4000", "postal_code": "23233", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to three direct accounts in NM, AZ and UT.", "recall_number": "D-0371-2024", "product_description": "Rocuronium Bromide Injection, Preservative Free, 10 mg / mL, Multiple-Dose Vial 10 mL, Rx only, Mfg: Auromedics Pharma LLC, NDC 55150-226-10", "product_quantity": "70 vials", "reason_for_recall": "cGMP Deviations: Products were stored outside the drug label specifications.", "recall_initiation_date": "20240207", "center_classification_date": "20240308", "termination_date": "20240814", "report_date": "20240320", "code_info": "1064081"}]